"LTPProtein	ProteinDomain	FullIdentityOfLipid	Lipid	Screen	Intensity	Adduct	TotalCarbonChainLength	TotalCarbonChainUnsaturations	IonMode	mz	MeanOfRetentionTime	MinimumOfRetentionTime	MaximumOfRetentionTime	LipidAmbiguity	LikelySubclass";;;;
"ATCAY	CRAL-TRIO	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	400000	[M+H]+	34	1	pos	760.5777	10.71	10.43	11.06	PC	PC";;;;
"ATCAY	CRAL-TRIO	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	260000	[M+H]+	32	1	pos	732.5496	9.38	7.65	10.42	PC	PC";;;;
"BNIPL	CRAL-TRIO	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	72000	[M+H]+	32	1	pos	718.5827	9.99	9.67	10.94	PC-O	PC-O";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	5800000	[M+H]+	34	1	pos	760.594	10.43	10.13	10.91	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in cellulo	3400000	[M+H]+	36	2	pos	786.6075	10.6	10.17	11.06	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	3300000	[M+H]+	32	1	pos	732.5633	9.16	8.88	9.79	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	1800000	[M+H]+	34	2	pos	758.5786	9.36	9.09	10.39	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-34:1)	PC(O-34:1)	in cellulo	770000	[M+H]+	34	1	pos	746.6128	11.3	11.02	11.91	PC-O	PC-O";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	470000	[M+H]+	32	1	pos	718.5836	10	9.75	10.88	PC-O	PC-O";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (36:1)	PC(36:1)	in cellulo	460000	[M+H]+	36	1	pos	788.6256	11.8	11.47	12.35	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in cellulo	390000	[M+H]+	32	2	pos	730.5483	8.2	7.98	9.01	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in cellulo	380000	[M+H]+	34	1	pos	718.5452	10.67	10.13	10.93	PE	PE";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in cellulo	310000	[M+H]+	36	3	pos	784.5949	9.68	9.36	10.58	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in cellulo	290000	[M+H]+	33	1	pos	746.5796	9.79	7.05	10.53	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (38:2)	PC(38:2)	in cellulo	260000	[M+H]+	38	2	pos	814.6418	11.89	11.42	12.7	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (30:0)	PC(30:0)	in cellulo	250000	[M+H]+	30	0	pos	706.548	8.94	7.93	9.31	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in cellulo	220000	[M+H]+	36	2	pos	744.5633	10.84	10.04	11.2	PE	PE";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (19:1)	PC(19:1)	in cellulo	200000	[M+H]+	19	1	pos	550.3504	3.89	2.99	4.14	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-36:2)	PC(O-36:2)	in cellulo	170000	[M+H]+	36	2	pos	772.6305	11.42	11.24	12.62	PC-O	PC-O";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	160000	[M+H]+	34	2	pos	744.6001	10.3	9.93	11.7	PC-O	PC-O";;;;
"BPI	LBP_BPI_CETP	[M+Na]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	160000	[M+Na]+	34	1	pos	782.5759	10.45	10.23	10.84	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylserine (36:1) => (18:1/18:0)	PS(36:1)	in cellulo	140000	[M+H]+	36	1	pos	790.5658	10.59	10.41	10.76	PS	PS";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in cellulo	100000	[M+H]+	34	2	pos	716.5328	9.56	9.36	10.06	PE	PE";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (17:1)	PC(17:1)	in cellulo	96000	[M+H]+	17	1	pos	522.3192	2.29	1.62	2.63	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylserine (34:1) => (18:1/16:0)	PS(34:1)	in cellulo	95000	[M+H]+	34	1	pos	762.5373	9.34	9.09	9.66	PS	PS";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (31:1)	PC(31:1)	in cellulo	93000	[M+H]+	31	1	pos	718.5475	8.57	8.25	9.93	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (32:0)	PC(32:0)	in cellulo	87000	[M+H]+	32	0	pos	734.5794	10.21	10.02	10.58	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+Na]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	86000	[M+Na]+	32	1	pos	754.5453	9.17	8.96	9.62	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+H]+: Phosphatidylethanolamine (32:1) => (16:1/16:0)	PE(32:1)	in cellulo	83000	[M+H]+	32	1	pos	690.5159	9.42	8.95	9.8	PE	PE";;;;
"BPI	LBP_BPI_CETP	[M+H]+:Phosphatidylethanolamine (38:4) => (18:0/20:4)	PE(38:4)	in cellulo	65000	[M+H]+	38	4	pos	768.5632	11.01	10.72	11.18	PE	PE";;;;
"BPI	LBP_BPI_CETP	[M+NH4]+: Phosphatidylinositol (34:1) => (16:0/18:1)	PI(34:1)	in cellulo	57000	[M+NH4]+	34	1	pos	854.587	9.17	8.87	9.45	PI	PI";;;;
"BPI	LBP_BPI_CETP	[M+HCOO]-: Phosphatidylcholine (34:1) => (18:1/16:0)	PC(34:1)	in cellulo	190000	[M+HCOO]-	34	1	neg	804.5748	10.39	10.2	10.76	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+HCOO]-: Phosphatidylcholine (32:1) => (16:1/16:0)	PC(32:1)	in cellulo	120000	[M+HCOO]-	32	1	neg	776.5439	9.13	8.94	9.54	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+HCOO]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in cellulo	110000	[M+HCOO]-	36	2	neg	830.59	10.54	10.33	10.96	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M+HCOO]-: Phosphatidylcholine (34:2) => (16:1/18:1)	PC(34:2)	in cellulo	75000	[M+HCOO]-	34	2	neg	802.5596	9.3	9.11	9.83	PC	PC";;;;
"BPI	LBP_BPI_CETP	[M-H]-: Phosphatidylinositol (36:2) => (18:1/18:1)	PI(36:2)	in cellulo	39000	[M-H]-	36	2	neg	861.549	9.28	9.03	9.7	PI	PI";;;;
"BPI	LBP_BPI_CETP	[M-H]-: Phosphatidylinositol (34:1) => (18:1/16:0)	PI(34:1)	in cellulo	31000	[M-H]-	34	1	neg	835.5328	9.14	8.87	9.4	PI	PI";;;;
"BPI	LBP_BPI_CETP	[M-H]-: Phosphatidylinositol (38:4) => (18:0/20:4)	PI(38:4)	in cellulo	30000	[M-H]-	38	4	neg	885.5487	9.46	9.15	9.58	PI	PI";;;;
"BPI	LBP_BPI_CETP	[M-H]-: Phosphatidylserine (34:1) => (16:0/18:1)	PS(34:1)	in cellulo	27000	[M-H]-	34	1	neg	760.5121	9.32	9.08	9.57	PS	PS";;;;
"BPI	LBP_BPI_CETP	[M-H]-: Phosphatidylinositol (36:1) => (18:1/18:0)	PI(36:1)	in cellulo	26000	[M-H]-	36	1	neg	863.5648	10.37	10.12	10.51	PI	PI";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	5000000	[M+H]+	34	1	pos	760.5775	10.62	10.37	11.07	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	2400000	[M+H]+	32	1	pos	732.5494	9.32	7.57	10.55	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in cellulo	2300000	[M+H]+	36	2	pos	786.5942	10.79	10.08	11.32	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	1900000	[M+H]+	34	2	pos	758.5646	9.59	9.11	11.2	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-34:1)	PC(O-34:1)	in cellulo	1000000	[M+H]+	34	1	pos	746.6012	11.5	11.22	12.06	PC-O	PC-O";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	690000	[M+H]+	32	1	pos	718.5694	10.36	9.87	11.19	PC-O	PC-O";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in cellulo	610000	[M+H]+	32	2	pos	730.5346	8.48	8.02	9.08	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (30:1)	PC(30:1)	in cellulo	490000	[M+H]+	30	1	pos	704.5175	8.18	7.8	8.69	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in cellulo	320000	[M+H]+	36	3	pos	784.5816	9.84	9.49	10.71	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in cellulo	300000	[M+H]+	33	1	pos	746.5627	9.95	9.31	10.65	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+NH4]+: Bismonoacylglycerolphosphate (36:2) => (18:1/18:1)	BMP(36:2)	in cellulo	300000	[M+NH4]+	36	2	pos	792.57	9.75	8.46	10	BMP	BMP";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-36:2)	PC(O-36:2)	in cellulo	210000	[M+H]+	36	2	pos	772.6164	11.66	11.4	12.82	PC-O	PC-O";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	200000	[M+H]+	34	2	pos	744.5848	10.47	10.03	11.09	PC-O	PC-O";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (36:1)	PC(36:1)	in cellulo	250000	[M+H]+	36	1	pos	788.6106	12.01	11.63	12.52	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (35:2)	PC(35:2)	in cellulo	190000	[M+H]+	35	2	pos	772.5836	10.33	9.56	11.2	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	160000	[M+H]+	34	2	pos	744.5852	11.31	11.02	11.73	PC-O	PC-O";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (34:3)	PC(34:3)	in cellulo	160000	[M+H]+	34	3	pos	756.5477	8.82	8.28	9.49	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+Na]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	150000	[M+Na]+	34	1	pos	782.5596	10.61	10.37	10.96	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (35:1)	PC(35:1)	in cellulo	140000	[M+H]+	35	1	pos	774.5956	11.03	10.71	11.6	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (30:0)	PC(30:0)	in cellulo	120000	[M+H]+	30	0	pos	706.5333	9.07	8.76	9.42	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (31:1)	PC(31:1)	in cellulo	110000	[M+H]+	31	1	pos	718.5345	8.68	8.28	9.21	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-32:0)	PC(O-32:0)	in cellulo	100000	[M+H]+	32	0	pos	720.5847	11.31	11.02	11.77	PC-O	PC-O";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (O-32:2)	PC(O-32:2)	in cellulo	96000	[M+H]+	32	2	pos	716.5536	10.2	8.9	10.89	PC-O	PC-O";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Phosphatidylcholine (17:1)	PC(17:1)	in cellulo	95000	[M+H]+	17	1	pos	522.3224	2.26	1.18	2.61	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+Na]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	68000	[M+Na]+	32	1	pos	754.53	9.33	9.03	9.78	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+H]+: Lysophosphatidylcholine (30:0)";" Phosphatidylcholine (O-30:0)	PC(O-30:0)/LPC(30:0)	in cellulo	56000	[M+H]+	30	0	pos	692.5547	9.9	9.61	10.25	PC-O";" Lyso-PC	PC-O";;
"BPIFB2	LBP_BPI_CETP	[M-H]-: Phosphatidylglycerol (36:2)";" Bismonoacylglycerolphosphate (36:2) => (18:1/18:1)	PG/BMP(36:2)	in cellulo	150000	[M-H]-	36	2	neg	773.5258	9.43	8.63	9.94	BMP";" PG	PG/BMP";;
"BPIFB2	LBP_BPI_CETP	[M+HCOO]-: Phosphatidylcholine (34:1) => (18:1/16:0)	PC(34:1)	in cellulo	140000	[M+HCOO]-	34	1	neg	804.5663	10.63	10.36	10.95	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+HCOO]-: Phosphatidylcholine (32:1) => (18:1/14:0)	PC(32:1)	in cellulo	77000	[M+HCOO]-	32	1	neg	776.5364	9.3	9.02	9.73	PC	PC";;;;
"BPIFB2	LBP_BPI_CETP	[M+HCOO]-: Phosphatidylcholine (34:2) => (18:1/16:1)	PC(34:2)	in cellulo	50000	[M+HCOO]-	34	2	neg	802.5518	9.56	9.22	9.94	PC	PC";;;;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*42:2)	HexCer(t*42:2)	in cellulo	1900000	[M+H]+	42	2	pos	826.6733	14	13.47	14.21	Hex-DHCer-OH"; Hex-tCer; Hex-dCer-OH;" Hex-dCer-OH	t*HexCer";
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*42:1)	HexCer(t*42:1)	in cellulo	1300000	[M+H]+	42	1	pos	828.6896	15.04	14.85	15.26	Hex-dCer-OH"; Hex-dCer-OH; Hex-tCer;" Hex-DHCer-OH	t*HexCer";
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*42:2)	HexCer(d*42:2)	in cellulo	1100000	[M+H]+	42	2	pos	810.6784	14.1	13.63	14.64	Hex-dCer"; Hex-dCer;" Hex-DHCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*40:2)	HexCer(t*40:2)	in cellulo	1000000	[M+H]+	40	2	pos	798.6398	12.57	12.06	13.19	Hex-dCer-OH"; Hex-tCer; Hex-dCer-OH;" Hex-DHCer-OH	t*HexCer";
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*40:1)	HexCer(t*40:1)	in cellulo	800000	[M+H]+	40	1	pos	800.6551	13.61	13.11	13.92	Hex-tCer"; Hex-DHCer-OH; Hex-dCer-OH;" Hex-dCer-OH	t*HexCer";
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*34:1)	HexCer(d*34:1)	in cellulo	740000	[M+H]+	34	1	pos	700.5683	9.84	9.39	10.06	Hex-dCer"; Hex-DHCer;" Hex-dCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*42:1)	HexCer(d*42:1)	in cellulo	650000	[M+H]+	42	1	pos	812.6936	15.51	15.26	15.71	Hex-dCer"; Hex-dCer;" Hex-DHCer	d*HexCer";;
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (t*42:2)	HexCer(t*42:2)	in cellulo	610000	[M+Na]+	42	2	pos	848.654	13.98	13.47	14.21	Hex-DHCer-OH"; Hex-tCer;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*40:1)	HexCer(d*40:1)	in cellulo	540000	[M+H]+	40	1	pos	784.6611	14.16	13.9	14.61	Hex-dCer"; Hex-DHCer;" Hex-dCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*34:1)	HexCer(t*34:1)	in cellulo	480000	[M+H]+	34	1	pos	716.5645	9.41	9.07	9.59	Hex-DHCer-OH"; Hex-dCer-OH; Hex-dCer-OH;" Hex-tCer	t*HexCer";
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (t*42:1)	HexCer(t*42:1)	in cellulo	460000	[M+Na]+	42	1	pos	850.669	15.04	14.85	15.26	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (d*42:2)	HexCer(d*42:2)	in cellulo	380000	[M+Na]+	42	2	pos	832.6606	14.11	13.88	14.6	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (d*42:1)	HexCer(d*42:1)	in cellulo	290000	[M+Na]+	42	1	pos	834.6757	15.5	15.3	15.67	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*42:3)	HexCer(t*42:3)	in cellulo	280000	[M+H]+	42	3	pos	824.6577	12.53	12.3	12.99	Hex-dCer-OH"; Hex-tCer; Hex-dCer-OH;" Hex-DHCer-OH	t*HexCer";
"GLTP	GLTP	 [M+Na]+: Hexosyl ceramide (t*40:2)	HexCer(t*40:2)	in cellulo	280000	[M+Na]+	40	2	pos	820.6242	12.56	12.3	12.76	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*42:3)	HexCer(d*42:3)	in cellulo	280000	[M+H]+	42	3	pos	808.6624	12.96	12.22	13.98	Hex-dCer"; Hex-dCer;" Hex-DHCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*36:1)	HexCer(d*36:1)	in cellulo	260000	[M+H]+	36	1	pos	728.6007	11.28	10.94	11.45	Hex-dCer"; Hex-dCer;" Hex-DHCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*41:2)	HexCer(t*41:2)	in cellulo	260000	[M+H]+	41	2	pos	812.6576	13.27	12.84	13.51	Hex-DHCer-OH"; Hex-dCer-OH; Hex-dCer-OH;" Hex-tCer	t*HexCer";
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (d*34:1)	HexCer(d*34:1)	in cellulo	240000	[M+Na]+	34	1	pos	722.5507	9.84	9.5	10.05	Hex-DHCer";" Hex-dCer	d*HexCer";;;
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (t*40:1)	HexCer(t*40:1)	in cellulo	240000	[M+Na]+	40	1	pos	822.6393	13.68	13.42	13.9	Hex-tCer"; Hex-DHCer-OH;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*34:2)	HexCer(t*34:2)	in cellulo	230000	[M+H]+	34	2	pos	714.5481	8.4	8	8.67	Hex-DHCer-OH"; Hex-dCer-OH; Hex-tCer;" Hex-dCer-OH	t*HexCer";
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*41:1)	HexCer(t*41:1)	in cellulo	220000	[M+H]+	41	1	pos	814.6734	14.37	14.13	14.56	Hex-tCer"; Hex-dCer-OH; Hex-dCer-OH;" Hex-DHCer-OH	t*HexCer";
"GLTP	GLTP	[M+H]+: Dihexosyl ceramide (t*42:2)	Hex2Cer(t*42:2)	in cellulo	200000	[M+H]+	42	2	pos	988.7286	13.35	12.84	13.57	Hex2-tCer"; Hex2-dCer-OH; Hex2-dCer-OH;" Hex2-DHCer-OH	t*Hex2Cer";
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (t*34:1)	HexCer(t*34:1)	in cellulo	110000	[M+Na]+	34	1	pos	738.5455	9.44	9.07	9.59	Hex-DHCer-OH"; Hex-dCer-OH;" Hex-tCer	t*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*36:2)	HexCer(d*36:2)	in cellulo	110000	[M+H]+	36	2	pos	726.5845	10.09	9.79	10.85	Hex-DHCer"; Hex-dCer;" Hex-dCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d*42:3)	HexCer(d*42:3)	in cellulo	100000	[M+H]+	42	3	pos	808.6611	14.22	13.76	14.55	Hex-dCer"; Hex-dCer;" Hex-DHCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t*36:2)	HexCer(t*36:2)	in cellulo	85000	[M+H]+	36	2	pos	742.5797	9.69	9.37	10.09	Hex-dCer-OH"; Hex-tCer; Hex-dCer-OH;" Hex-DHCer-OH	t*HexCer";
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (d*36:1)	HexCer(d*36:1)	in cellulo	78000	[M+Na]+	36	1	pos	750.5803	11.28	10.98	11.42	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*42:2)	HexCer(t*42:2)	in cellulo	780000	[M+HCOO]-	42	2	neg	870.6591	13.96	13.49	14.18	Hex-DHCer-OH"; Hex-tCer;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*42:1)	HexCer(t*42:1)	in cellulo	530000	[M+HCOO]-	42	1	neg	872.6748	15.01	14.82	15.22	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*40:2)	HexCer(t*40:2)	in cellulo	410000	[M+HCOO]-	40	2	neg	842.6281	12.54	12.29	12.75	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*42:2)	HexCer(d*42:2)	in cellulo	320000	[M+HCOO]-	42	2	neg	854.6645	14.08	13.88	14.6	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*34:1)	HexCer(d*34:1)	in cellulo	280000	[M+HCOO]-	34	1	neg	744.5553	9.83	9.52	10.04	Hex-DHCer";" Hex-dCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*34:1)	HexCer(t*34:1)	in cellulo	220000	[M+HCOO]-	34	1	neg	760.5502	9.41	9.1	9.61	Hex-DHCer-OH"; Hex-dCer-OH;" Hex-tCer	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*42:1)	HexCer(d*42:1)	in cellulo	220000	[M+HCOO]-	42	1	neg	856.6801	15.46	15.3	15.68	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (t*42:2)	HexCer(t*42:2)	in cellulo	210000	[M+HCOO+1x(HCOONa)]-	42	2	neg	938.6456	13.96	13.5	14.18	Hex-DHCer-OH"; Hex-tCer;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*40:1)	HexCer(d*40:1)	in cellulo	200000	[M+HCOO]-	40	1	neg	828.649	14.12	13.92	14.35	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (t*42:1)	HexCer(t*42:1)	in cellulo	160000	[M+HCOO+1x(HCOONa)]-	42	1	neg	940.6612	15.01	14.84	15.22	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*40:2)	HexCer(d*40:2)	in cellulo	110000	[M+HCOO]-	40	2	neg	826.6337	13	12.54	13.29	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*42:3)	HexCer(t*42:3)	in cellulo	100000	[M+HCOO]-	42	3	neg	868.6435	12.51	12.29	13	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (t*40:2)	HexCer(t*40:2)	in cellulo	100000	[M+HCOO+1x(HCOONa)]-	40	2	neg	910.6147	12.52	12.29	12.75	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (t*40:1)	HexCer(t*40:1)	in cellulo	90000	[M+HCOO+1x(HCOONa)]-	40	1	neg	912.631	13.66	13.46	13.88	Hex-tCer"; Hex-DHCer-OH;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*36:1)	HexCer(d*36:1)	in cellulo	87000	[M+HCOO]-	36	1	neg	772.5868	11.25	11	11.46	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*41:1)	HexCer(t*41:1)	in cellulo	84000	[M+HCOO]-	41	1	neg	858.6589	14.35	14.14	14.55	Hex-tCer"; Hex-dCer-OH;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*34:2)	HexCer(t*34:2)	in cellulo	83000	[M+HCOO]-	34	2	neg	758.5352	8.4	8.01	8.64	Hex-DHCer-OH"; Hex-dCer-OH;" Hex-tCer	t*HexCer";;
"GLTP	GLTP	[M+HCOO+2x(HCOONa)]-: Hexosyl ceramide (t*42:2)	HexCer(t*42:2)	in cellulo	83000	[M+HCOO+2x(HCOONa)]-	42	2	neg	1006.6314	13.96	13.5	14.18	Hex-DHCer-OH"; Hex-tCer;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (d*34:1)	HexCer(d*34:1)	in cellulo	63000	[M+HCOO+1x(HCOONa)]-	34	1	neg	812.5428	9.85	9.52	9.99	Hex-DHCer";" Hex-dCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO+2x(HCOONa)]-: Hexosyl ceramide (t*42:1)	HexCer(t*42:1)	in cellulo	60000	[M+HCOO+2x(HCOONa)]-	42	1	neg	1008.6491	15.03	14.84	15.22	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*42:3)	HexCer(d*42:3)	in cellulo	57000	[M+HCOO]-	42	3	neg	852.6489	12.94	12.75	13.33	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (d*42:1)	HexCer(d*42:1)	in cellulo	56000	[M+HCOO+1x(HCOONa)]-	42	1	neg	924.6668	15.47	15.35	15.68	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (t*34:1)	HexCer(t*34:1)	in cellulo	49000	[M+HCOO+1x(HCOONa)]-	34	1	neg	828.5377	9.4	9.1	9.56	Hex-DHCer-OH"; Hex-dCer-OH;" Hex-tCer	t*HexCer";;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (d*40:1)	HexCer(d*40:1)	in cellulo	46000	[M+HCOO+1x(HCOONa)]-	40	1	neg	896.6356	14.13	13.96	14.31	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO+2x(HCOONa)]-: Hexosyl ceramide (t*40:2)	HexCer(t*40:2)	in cellulo	41000	[M+HCOO+2x(HCOONa)]-	40	2	neg	978.6012	12.54	12.29	12.71	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO+3x(HCOONa)]-: Hexosyl ceramide (t*42:2)	HexCer(t*42:2)	in cellulo	35000	[M+HCOO+3x(HCOONa)]-	42	2	neg	1074.6178	13.96	13.84	14.18	Hex-DHCer-OH"; Hex-tCer;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO+2x(HCOONa)]-: Hexosyl ceramide (t*40:1)	HexCer(t*40:1)	in cellulo	34000	[M+HCOO+2x(HCOONa)]-	40	1	neg	980.6165	13.67	13.5	13.88	Hex-tCer"; Hex-DHCer-OH;" Hex-dCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*36:2)	HexCer(d*36:2)	in cellulo	32000	[M+HCOO]-	36	2	neg	770.571	10.08	9.82	10.41	Hex-DHCer";" Hex-dCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO+3x(HCOONa)]-: Hexosyl ceramide (t*42:1)	HexCer(t*42:1)	in cellulo	32000	[M+HCOO+3x(HCOONa)]-	42	1	neg	1076.6343	15	14.89	15.18	Hex-dCer-OH"; Hex-tCer;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t*36:2)	HexCer(t*36:2)	in cellulo	25000	[M+HCOO]-	36	2	neg	786.5657	9.7	9.39	9.82	Hex-tCer"; Hex-dCer-OH;" Hex-DHCer-OH	t*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d*41:1)	HexCer(d*41:1)	in cellulo	24000	[M+HCOO]-	41	1	neg	842.6648	14.82	14.64	14.97	Hex-dCer";" Hex-DHCer	d*HexCer";;;
"GLTP	GLTP	[M+HCOO]-: Dihexosyl ceramide (t*40:2)	Hex2Cer(t*40:2)	in cellulo	23000	[M+HCOO]-	40	2	neg	1004.6798	11.91	11.67	12.12	Hex2-tCer"; Hex2-DHCer-OH;" Hex2-dCer-OH	t*Hex2Cer";;
"GLTP	GLTP	[M+HCOO+1x(HCOONa)]-: Hexosyl ceramide (t*34:2)	HexCer(t*34:2)	in cellulo	18000	[M+HCOO+1x(HCOONa)]-	34	2	neg	826.5219	8.4	8.1	8.55	Hex-DHCer-OH"; Hex-dCer-OH;" Hex-tCer	t*HexCer";;
"GLTP	GLTP	[M+HCOO+2x(HCOONa)]-: Hexosyl ceramide (t*34:1)	HexCer(t*34:1)	in cellulo	17000	[M+HCOO+2x(HCOONa)]-	34	1	neg	896.5239	9.4	9.14	9.53	Hex-DHCer-OH"; Hex-dCer-OH;" Hex-tCer	t*HexCer";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	3700000	[M+H]+	34	1	pos	703.5845	8.78	8.36	9.02	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	2100000	[M+H]+	34	1	pos	618.4385	8.39	7.61	8.76	dCer-1P"; DHCer-1P;" dCer-1P	d*CerP";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*42:2)	SM(d*42:2)	in cellulo	1300000	[M+H]+	42	2	pos	813.6928	12.84	12.58	13.34	DHSM";" dSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*40:1)	SM(d*40:1)	in cellulo	890000	[M+H]+	40	1	pos	787.6771	12.89	12.62	13.18	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*40:2)	SM(d*40:2)	in cellulo	680000	[M+H]+	40	2	pos	785.6626	11.49	11.22	12.36	DHSM";" dSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*34:2)	SM(d*34:2)	in cellulo	390000	[M+H]+	34	2	pos	701.5693	7.86	7.48	8.29	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Ceramide phosphate (d*42:2)	CerP(d*42:2)	in cellulo	330000	[M+H]+	42	2	pos	728.6052	12.22	11.82	13.38	dCer-1P"; dCer-1P;" DHCer-1P	d*CerP";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*36:1)	SM(d*36:1)	in cellulo	300000	[M+H]+	36	1	pos	731.6162	10.1	9.78	10.37	DHSM";" dSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*42:3)	SM(d*42:3)	in cellulo	300000	[M+H]+	42	3	pos	811.6796	11.74	11.49	12.12	DHSM";" dSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*32:1)	SM(d*32:1)	in cellulo	270000	[M+H]+	32	1	pos	675.5527	7.64	7.26	7.81	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*38:1)	SM(d*38:1)	in cellulo	270000	[M+H]+	38	1	pos	759.6471	11.48	11.18	11.78	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Ceramide phosphate (d*34:2)	CerP(d*34:2)	in cellulo	240000	[M+H]+	34	2	pos	616.4237	7.55	6.78	7.94	DHCer-1P"; dCer-1P;" dCer-1P	d*CerP";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*41:2)	SM(d*41:2)	in cellulo	200000	[M+H]+	41	2	pos	799.6782	12.15	11.87	12.77	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Ceramide phosphate (d*32:1)	CerP(d*32:1)	in cellulo	200000	[M+H]+	32	1	pos	590.463	7.36	6.63	7.59	DHCer-1P"; dCer-1P;" dCer-1P	d*CerP";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*42:1)	SM(d*42:1)	in cellulo	180000	[M+H]+	42	1	pos	815.7106	14.29	14.02	14.62	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*33:1)	SM(d*33:1)	in cellulo	160000	[M+H]+	33	1	pos	689.5686	8.21	7.83	8.37	DHSM";" dSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (DH34:0)	SM(DH34:0)	in cellulo	150000	[M+H]+	34	0	pos	705.5998	9.27	8.43	9.54	DHSM	DHSM";;;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d*36:2)	SM(d*36:2)	in cellulo	140000	[M+H]+	36	2	pos	729.6006	9.04	8.7	9.54	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+Na]+: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	120000	[M+Na]+	34	1	pos	725.5671	8.78	8.43	8.98	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+H]+: Ceramide phosphate (d*40:1)	CerP(d*40:1)	in cellulo	120000	[M+H]+	40	1	pos	702.5904	12.2	11.78	12.69	dCer-1P"; DHCer-1P;" dCer-1P	d*CerP";;
"GLTPD1	GLTP	[M+HCOOH]+: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	110000	[M+HCOOH]+	34	1	pos	663.4919	8.36	7.76	8.72	dCer-1P"; DHCer-1P;" dCer-1P	d*CerP";;
"GLTPD1	GLTP	[M+H]+: Ceramide phosphate (d*36:2)	CerP(d*36:2)	in cellulo	95000	[M+H]+	36	2	pos	644.4521	8.62	8.03	9.37	dCer-1P"; DHCer-1P;" dCer-1P	d*CerP";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (t*34:2)	SM(t*34:2)	in cellulo	50000	[M+H]+	34	2	pos	717.5641	7.49	7.13	7.72	DHSM-OH"; tSM;" dSM-OH	t*SM";;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	1100000	[M-H]-	34	1	neg	616.4708	8.39	7.75	8.71	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	480000	[M+HCOO]-	34	1	neg	747.5655	8.78	8.41	8.96	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*42:2)	CerP(d*42:2)	in cellulo	150000	[M-H]-	42	2	neg	726.5801	12.17	11.88	13	dCer-1P";" DHCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H]-:Ceramide phosphate (d*34:2)	CerP(d*34:2)	in cellulo	140000	[M-H]-	34	2	neg	614.4554	7.53	6.99	7.91	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*32:1)	CerP(d*32:1)	in cellulo	130000	[M-H]-	32	1	neg	588.4392	7.35	6.78	7.58	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H+1x(HCOONa)]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	110000	[M-H+1x(HCOONa)]-	34	1	neg	684.4581	8.37	7.87	8.62	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H+2x(HCOONa)]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	94000	[M-H+2x(HCOONa)]-	34	1	neg	752.4457	8.37	7.87	8.62	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d*42:2)	SM(d*42:2)	in cellulo	92000	[M+HCOO]-	42	2	neg	857.6749	12.82	12.58	13.27	DHSM";" dSM	d*SM";;;
"GLTPD1	GLTP	[M+HCOO+1x(HCOONa)]-: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	66000	[M+HCOO+1x(HCOONa)]-	34	1	neg	815.5522	8.77	8.41	8.96	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d*40:1)	SM(d*40:1)	in cellulo	66000	[M+HCOO]-	40	1	neg	831.6593	12.86	12.62	13.1	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*42:3)	CerP(d*42:3)	in cellulo	60000	[M-H]-	42	3	neg	724.5648	11.15	10.88	11.68	dCer-1P";" DHCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M+HCOO+2x(HCOONa)]-: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	58000	[M+HCOO+2x(HCOONa)]-	34	1	neg	883.5402	8.75	8.41	8.95	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*40:1)	CerP(d*40:1)	in cellulo	57000	[M-H]-	40	1	neg	700.5646	12.24	11.96	12.64	dCer-1P";" DHCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H+Na+5x(HCOONa)]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	53000	[M-2H+Na+5x(HCOONa)]-	34	1	neg	978.3899	8.37	7.9	8.62	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H+3x(HCOONa)]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	53000	[M-H+3x(HCOONa)]-	34	1	neg	820.4336	8.37	7.87	8.57	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M+HCOO+3x(HCOONa)]-: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	46000	[M+HCOO+3x(HCOONa)]-	34	1	neg	951.5279	8.77	8.45	8.96	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M-H]-:Ceramide phosphate (d*36:1)	CerP(d*36:1)	in cellulo	46000	[M-H]-	36	1	neg	644.5023	9.58	9.16	9.87	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H+Na+4x(HCOONa)]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	46000	[M-2H+Na+4x(HCOONa)]-	34	1	neg	910.4024	8.37	7.87	8.54	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*36:2)	CerP(d*36:2)	in cellulo	44000	[M-H]-	36	2	neg	642.4863	8.62	8.15	9.04	dCer-1P";" DHCer-1P	d*CerP";;;
"GLTPD1	GLTP	 [M+HCOO]-: Sphingomyelin (d*34:2)	SM(d*34:2)	in cellulo	41000	[M+HCOO]-	34	2	neg	745.5503	7.84	7.48	8.21	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M-H+Na+6x(HCOONa)]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	41000	[M-2H+Na+6x(HCOONa)]-	34	1	neg	1046.377	8.37	7.87	8.62	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M-H+Na+3x(HCOONa)]-: Ceramide phosphate (d*34:1)	CerP(d*34:1)	in cellulo	40000	[M-2H+Na+3x(HCOONa)]-	34	1	neg	842.4151	8.37	7.9	8.58	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M+HCOO+4x(HCOONa)]-: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	38000	[M+HCOO+4x(HCOONa)]-	34	1	neg	1019.5143	8.77	8.45	8.92	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d*36:1)	SM(d*36:1)	in cellulo	32000	[M+HCOO]-	36	1	neg	775.5966	10.06	9.83	10.29	DHSM";" dSM	d*SM";;;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*33:1)	CerP(d*33:1)	in cellulo	31000	[M-H]-	33	1	neg	602.4552	7.82	7.33	8.04	DHCer-1P";" dCer-1P	d*CerP";;;
"GLTPD1	GLTP	[M+HCOO+5x(HCOONa)]-: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	31000	[M+HCOO+5x(HCOONa)]-	34	1	neg	1087.5026	8.77	8.49	8.91	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d*32:1)	SM(d*32:1)	in cellulo	30000	[M+HCOO]-	32	1	neg	719.5342	7.65	7.27	7.77	dSM";" DHSM	d*SM";;;
"GLTPD1	GLTP	[M-H]-: Ceramide phosphate (d*32:2)	CerP(d*32:2)	in cellulo	20000	[M-H]-	32	2	neg	586.4243	6.64	6.11	6.89	DHCer-1P";" dCer-1P	d*CerP";;;
"GM2A	ML	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in cellulo	470000	[M+H]+	33	1	pos	746.5571	9.16	9.04	11.26	PC	PC";;;;
"GM2A	ML	[M+H]+: Phosphatidylcholine (40:2)	PC(40:2)	in cellulo	420000	[M+H]+	40	2	pos	842.6587	13.79	13.58	14.42	PC	PC";;;;
"GM2A	ML	[M+H]+: Phosphatidylcholine (O-38:3)	PC(O-38:3)	in cellulo	390000	[M+H]+	38	3	pos	798.6334	12.72	12.07	13.66	PC-O	PC-O";;;;
"GM2A	ML	[M+H]+: Phosphatidylcholine (O-37:7)	PC(O-37:7)	in cellulo	150000	[M+H]+	37	7	pos	776.5535	11.12	10.88	11.41	PC-O	PC-O";;;;
"GM2A	ML	[M+H]+: Phosphatidylcholine (O-36:5)	PC(O-36:5)	in cellulo	150000	[M+H]+	36	5	pos	766.5686	9.85	9.75	10.15	PC-O	PC-O";;;;
"GM2A	ML	[M-H]-: Phosphatidylinositol (34:1) =>(18:1/16:0)	PI(34:1)	in cellulo	260000	[M-H]-	34	1	neg	835.5255	9.63	9.15	9.99	PI	PI";;;;
"GM2A	ML	[M-H]-: Phosphatidylglycerol (38:3)";" Bismonoacylglycerolphosphate (38:3) => (20:2/18:1)	PG/BMP(38:3)	in cellulo	150000	[M-H]-	38	3	neg	799.54	9.77	9.19	10.46	BMP";" PG	PG/BMP";;
"GM2A	ML	[M-H]-: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in cellulo	150000	[M-H]-	34	2	neg	714.4999	10.12	9.82	10.54	PE	PE";;;;
"GM2A	ML	[M-H]-: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in cellulo	140000	[M-H]-	34	1	neg	716.5157	11.3	11.01	11.51	PE	PE";;;;
"GM2A	ML	[M+HCOO]-: Phosphatidylcholine (31:1) => (16:1/15:0)	PC(31:1)	in cellulo	92000	[M+HCOO]-	31	1	neg	762.5208	8.93	8.55	9.61	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	5100000	[M+H]+	32	1	pos	732.5501	9.34	8.58	10.19	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (36:2) 	PC(36:2)	in cellulo	5000000	[M+H]+	36	2	pos	786.595	10.82	9.9	11.29	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	4900000	[M+H]+	34	1	pos	760.5771	10.66	10.36	11.09	PC	PC";;;;
"LCN1	lipocalin	[M+H]+:  Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	4000000	[M+H]+	34	2	pos	758.5638	9.59	9.19	10.61	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in cellulo	2400000	[M+H]+	32	2	pos	730.5339	8.48	8	9.81	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (30:1)	PC(30:1)	in cellulo	1800000	[M+H]+	30	1	pos	704.5178	8.17	7.78	8.65	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	1500000	[M+H]+	32	1	pos	718.5698	10.28	9.85	11.17	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (O-34:1)	PC(O-34:1)	in cellulo	1000000	[M+H]+	34	1	pos	746.6012	11.56	11.21	12.08	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in cellulo	660000	[M+H]+	33	1	pos	746.5643	10.06	6.96	10.66	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (34:3)	PC(34:3)	in cellulo	520000	[M+H]+	34	3	pos	756.5482	8.7	8.3	9.44	PC	PC";;;;
"LCN1	lipocalin	[M+H]+:Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	470000	[M+H]+	34	2	pos	744.5844	10.49	10.02	11.01	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (31:1)	PC(31:1)	in cellulo	440000	[M+H]+	31	1	pos	718.5338	8.74	8.21	10.09	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (36:1)	PC(36:1)	in cellulo	380000	[M+H]+	36	1	pos	788.6105	12.09	11.73	12.5	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (O-36:2)	PC(O-36:2)	in cellulo	350000	[M+H]+	36	2	pos	772.6176	11.69	11.41	12.85	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (O-32:2)	PC(O-32:2)	in cellulo	320000	[M+H]+	32	2	pos	716.5531	10.09	8.93	10.6	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	300000	[M+H]+	34	2	pos	744.5856	11.29	11.02	11.78	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (36:4)	PC(36:4)	in cellulo	280000	[M+H]+	36	4	pos	782.5635	9.53	8.43	10.43	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (33:2) 	PC(33:2)	in cellulo	260000	[M+H]+	33	2	pos	744.55	8.97	8.55	10.09	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (38:5)	PC(38:5)	in cellulo	230000	[M+H]+	38	5	pos	808.5804	9.65	9.11	10.17	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (30:0)	PC(30:0)	in cellulo	230000	[M+H]+	30	0	pos	706.5332	9.13	8.68	9.45	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (38:6)	PC(38:6)	in cellulo	210000	[M+H]+	38	6	pos	806.5648	9.28	8.21	10.17	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (O-38:6)	PC(O-38:6)	in cellulo	160000	[M+H]+	38	6	pos	792.585	10.23	9.81	10.85	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+Na]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	150000	[M+Na]+	32	1	pos	754.5295	9.32	9.02	9.81	PC	PC";;;;
"LCN1	lipocalin	[M+Na]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	140000	[M+Na]+	34	1	pos	782.5602	10.65	10.39	10.97	PC	PC";;;;
"LCN1	lipocalin	[M+Na]+:  Phosphatidylcholine (36:2)	PC(36:2)	in cellulo	140000	[M+Na]+	36	2	pos	808.5768	10.79	10.52	11.13	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Lysophosphatidylcholine (38:5)";" Phosphatidylcholine (O-38:5)	PC(O-38:5)/LPC(38:5)	in cellulo	140000	[M+H]+	38	5	pos	794.5989	10.49	10.07	11.17	PC-O";" Lyso-PC	PC-O";;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (31:0)	PC(31:0)	in cellulo	120000	[M+H]+	31	0	pos	720.549	9.51	9.19	9.89	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (40:7)	PC(40:7)	in cellulo	120000	[M+H]+	40	7	pos	832.5811	9.4	8.93	9.77	PC	PC";;;;
"LCN1	lipocalin	[M+Na]+: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	110000	[M+Na]+	34	2	pos	780.5453	9.53	9.19	10.11	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Phosphatidylcholine (30:2)	PC(30:2)	in cellulo	130000	[M+H]+	30	2	pos	702.503	7.56	7	8.22	PC	PC";;;;
"LCN1	lipocalin	[M+H]+: Sphingomyelin (d*34:1)	SM(d*34:1)	in cellulo	92000	[M+H]+	34	1	pos	703.5703	9.02	8.68	9.27	dSM";" DHSM	d*SM";;;
"LCN1	lipocalin	[M+H]+:Phosphatidylcholine (O-38:7)	PC(O-38:7)	in cellulo	65000	[M+H]+	38	7	pos	790.5694	9.84	9.36	10.19	PC-O	PC-O";;;;
"LCN1	lipocalin	[M+HCOO]-: Phosphatidylcholine (32:1) => (16:1/16:0)	PC(32:1)	in cellulo	140000	[M+HCOO]-	32	1	neg	776.5365	9.33	9.03	9.79	PC	PC";;;;
"LCN1	lipocalin	[M+HCOO]-: Phosphatidylcholine (34:1) => (18:1/16:0)	PC(34:1)	in cellulo	110000	[M+HCOO]-	34	1	neg	804.5664	10.64	10.38	10.93	PC	PC";;;;
"LCN1	lipocalin	[M+HCOO]-: Phosphatidylcholine (34:2) => (16:1/18:1)	PC(34:2)	in cellulo	100000	[M+HCOO]-	34	2	neg	802.5513	9.5	9.24	10.08	PC	PC";;;;
"OSBPL9	OSBP	[M+H]+: Phosphatidylserine (36:1) => (18:1/18:0)	PS(36:1)	in cellulo	210000	[M+H]+	36	1	pos	790.5675	10.59	10.22	10.79	PS	PS";;;;
"OSBPL9	OSBP	[M+H]+: Phosphatidylserine (34:1) => (18:1/16:0)	PS(34:1)	in cellulo	100000	[M+H]+	34	1	pos	762.5385	9.33	8.9	9.69	PS	PS";;;;
"OSBPL9	OSBP	[M+H]+: Phosphatidylserine (36:2) => (18:1/18:1)	PS(36:2)	in cellulo	88000	[M+H]+	36	2	pos	788.5539	9.5	9.03	9.97	PS	PS";;;;
"OSBPL9	OSBP	[M-H]-: Phosphatidylserine (36:1) => (18:0/18:1)	PS(36:1)	in cellulo	51000	[M-H]-	36	1	neg	788.5443	10.55	10.37	10.71	PS	PS";;;;
"OSBPL9	OSBP	[M-H]-: Phosphatidylserine (34:1) => (16:0/18:1)	PS(34:1)	in cellulo	41000	[M-H]-	34	1	neg	760.5137	9.31	9.07	9.62	PS	PS";;;;
"OSBPL9	OSBP	[M-H]-: Phosphatidylserine (36:2) => (18:1/18:1)	PS(36:2)	in cellulo	27000	[M-H]-	36	2	neg	786.5298	9.45	9.29	9.84	PS	PS";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in cellulo	130000	[M+H]+	33	1	pos	746.5789	9.68	9.14	10.54	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (30:1)	PC(30:1)	in cellulo	120000	[M+H]+	30	1	pos	704.5321	7.91	7.58	8.38	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	380000	[M+H]+	32	1	pos	732.5632	9.14	7.14	10.41	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	340000	[M+H]+	34	1	pos	760.5938	10.4	10.07	10.9	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	210000	[M+H]+	34	2	pos	758.5788	9.4	9	10.73	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (30:0)	PC(30:0)	in cellulo	33000	[M+H]+	30	0	pos	706.5481	8.88	8.65	9.14	PC	PC";;;;
"RBP1	lipocalin	[M+H-H2O]+: Retinol	VA	in cellulo	290000	[M+H-H2O]+	NA	NA	pos	269.2245	4.79	4.11	4.92	VA	VA";;;;
"RBP4	lipocalin	[M+H-H2O]+: Retinol	VA	in cellulo	760000	[M+H-H2O]+	NA	NA	pos	269.2245	4.73	3.82	4.85	VA	VA";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Phosphatidylinositol (38:3)	PI(38:3)	in cellulo	920000	[M+NH4]+	38	3	pos	906.6022	10.81	9.6	11	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Phosphatidylinositol (38:4)	PI(38:4)	in cellulo	800000	[M+NH4]+	38	4	pos	904.589	9.83	8.75	10.14	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Phosphatidylinositol (38:2) => (18:0/20:2)	PI(38:2)	in cellulo	460000	[M+NH4]+	38	2	pos	908.6174	11.1	10.61	11.6	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Phosphatidylinositol (36:2) => (18:1/18:1)	PI(36:2)	in cellulo	380000	[M+NH4]+	36	2	pos	880.587	9.75	9.34	10.27	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M+Na]+: Diacylglycerol (32:1) => (16:0/16:1)	DAG(32:1)	in cellulo	240000	[M+Na]+	32	1	pos	589.4771	12.38	12.05	12.74	DAG	DAG";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Diacylglycerol (32:1) => (16:0/16:1)	DAG(32:1)	in cellulo	230000	[M+NH4]+	32	1	pos	584.5212	12.37	12.05	12.79	DAG	DAG";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Phosphatidylinositol (36:1) => (18:1/18:0)	PI(36:1)	in cellulo	210000	[M+NH4]+	36	1	pos	882.601	10.89	10.57	11.09	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Phosphatidylinositol (38:5) => (18:1/20:4)	PI(38:5)	in cellulo	190000	[M+NH4]+	38	5	pos	902.5725	8.83	8.36	9.26	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M+NH4]+: Diacylglycerol (34:2) => (18:1/16:1)	DAG(34:2)	in cellulo	200000	[M+NH4]+	34	2	pos	610.4819	12.6	12.26	13.01	DAG	DAG";;;;
"SEC14L2	CRAL-TRIO	[M-H]-: Phosphatidylinositol (38:3) => (20:3/18:0)	PI(38:3)	in cellulo	570000	[M-H]-	38	3	neg	887.5563	10.79	9.52	10.97	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M-H]-: Phosphatidylinositol (38:2) => (20:2/18:0)	PI(38:2)	in cellulo	160000	[M-H]-	38	2	neg	889.5726	11.17	10.7	11.58	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M-H]-: Phosphatidylinositol (38:5) => (18:1/20:4)	PI(38:5)	in cellulo	95000	[M-H]-	38	5	neg	883.5256	8.8	8.23	9.16	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M-H]-: Phosphatidylinositol (36:1) => (18:1/18:0)	PI(36:1)	in cellulo	85000	[M-H]-	36	1	neg	863.5567	10.83	10.49	11.04	PI	PI";;;;
"SEC14L2	CRAL-TRIO	[M-H]-: Phosphatidylinositol (34:1) => (16:0/18:1)	PI(34:1)	in cellulo	30000	[M-H]-	34	1	neg	835.5264	9.55	9.14	9.69	PI	PI";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	1400000	[M+H]+	34	1	pos	760.595	10.36	10.12	10.72	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	900000	[M+H]+	32	1	pos	732.5641	9.12	8.9	9.5	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (O-34:1)	PC(O-34:1)	in cellulo	390000	[M+H]+	34	1	pos	746.6149	11.19	10.95	11.59	PC-O	PC-O";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	270000	[M+H]+	32	1	pos	718.5848	9.9	9.66	10.42	PC-O	PC-O";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (36:1)	PC(36:1)	in cellulo	190000	[M+H]+	36	1	pos	788.6264	11.71	11.41	12.1	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+:Phosphatidylcholine (30:0)	PC(30:0)	in cellulo	160000	[M+H]+	30	0	pos	706.5484	8.9	8.72	9.13	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (O-32:0)	PC(O-32:0)	in cellulo	150000	[M+H]+	32	0	pos	720.6004	11	10.78	11.33	PC-O	PC-O";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (32:0)	PC(32:0)	in cellulo	130000	[M+H]+	32	0	pos	734.5799	10.16	9.98	10.42	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in cellulo	110000	[M+H]+	32	2	pos	730.5487	8.14	7.8	10.39	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in cellulo	90000	[M+H]+	34	1	pos	718.5476	10.65	10.21	10.87	PE	PE";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in cellulo	77000	[M+H]+	33	1	pos	746.5799	9.72	7.8	11.1	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in cellulo	73000	[M+H]+	36	3	pos	784.5956	9.61	9.37	10.46	PC	PC";;;;
"SEC14L6	CRAL-TRIO	[M+H]+: Lysophosphatidylcholine (30:0)";" Phosphatidylcholine (O-30:0)	PC(O-30:0)/LPC(30:0)	in cellulo	61000	[M+H]+	30	0	pos	692.5689	9.67	9.46	9.9	PC-O";" Lyso-PC	PC-O";;
"SEC14L6	CRAL-TRIO	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	55000	[M+H]+	34	2	pos	744.6006	10.05	9.81	10.63	PC-O	PC-O";;;;
"SEC14L6	CRAL-TRIO	[M+Na]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	47000	[M+Na]+	34	1	pos	782.5766	10.37	10.16	10.63	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	17000000	[M+H]+	34	1	pos	760.578	10.98	10.72	11.41	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:2) 	PC(36:2)	in cellulo	16000000	[M+H]+	36	2	pos	786.5944	11.13	10.76	11.64	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (34:2) 	PC(34:2)	in cellulo	11000000	[M+H]+	34	2	pos	758.5645	9.94	9.49	10.98	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	11000000	[M+H]+	32	1	pos	732.5499	9.8	6.93	11.53	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	3300000	[M+H]+	32	1	pos	718.5704	10.69	10.26	11.46	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in cellulo	3200000	[M+H]+	32	2	pos	730.5345	8.74	8.34	9.5	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in cellulo	2700000	[M+H]+	36	3	pos	784.5806	10.19	9.76	11.05	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:6)	PC(38:6)	in cellulo	1700000	[M+H]+	38	6	pos	806.5657	9.64	8.47	10.21	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:5)	PC(38:5)	in cellulo	1700000	[M+H]+	38	5	pos	808.5819	10.03	9.49	10.58	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:7)	PC(40:7)	in cellulo	1500000	[M+H]+	40	7	pos	832.5814	9.79	9.49	10.12	PC	PC";;;;
"STARD2	START	[M+H]+: Lysophosphatidylcholine (38:5)";" Phosphatidylcholine (O-38:5)	PC(O-38:5)/LPC(38:5)	in cellulo	1800000	[M+H]+	38	5	pos	794.5998	10.86	10.35	12.04	PC-O";" Lyso-PC	PC-O";;
"STARD2	START	[M+H]+:  Phosphatidylcholine (36:4)	PC(36:4)	in cellulo	1600000	[M+H]+	36	4	pos	782.5646	9.9	8.94	10.21	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:1)	PC(36:1)	in cellulo	1300000	[M+H]+	36	1	pos	788.6122	12.41	12.15	12.83	PC	PC";;;;
"STARD2	START	[M+H]+:Phosphatidylcholine (O-40:7)	PC(O-40:7)	in cellulo	1200000	[M+H]+	40	7	pos	818.6016	10.57	9.72	11.08	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (30:1)	PC(30:1)	in cellulo	1200000	[M+H]+	30	1	pos	704.5179	8.54	8.1	8.91	PC	PC";;;;
"STARD2	START	[M+H]+:Phosphatidylcholine (O-38:6)	PC(O-38:6)	in cellulo	1100000	[M+H]+	38	6	pos	792.5859	10.48	9.78	11.16	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in cellulo	1100000	[M+H]+	33	1	pos	746.5662	10.29	9.28	10.85	PC	PC";;;;
"STARD2	START	[M+H]+:Phosphatidylcholine (O-36:2)	PC(O-36:2)	in cellulo	1100000	[M+H]+	36	2	pos	772.6164	12.01	11.72	12.65	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	1100000	[M+H]+	34	2	pos	744.5854	10.86	10.39	11.4	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (34:3)	PC(34:3)	in cellulo	980000	[M+H]+	34	3	pos	756.5484	9.09	8.6	9.96	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:3) 	PC(38:3)	in cellulo	670000	[M+H]+	38	3	pos	812.6126	11.77	10.39	12.42	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	660000	[M+H]+	34	2	pos	744.5865	11.66	11.38	12.12	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-32:2)	PC(O-32:2)	in cellulo	800000	[M+H]+	32	2	pos	716.5538	10.47	9.54	11.09	PC-O	PC-O";;;;
"STARD2	START	[M+H]+:Phosphatidylcholine (O-36:4)";" Lysophosphatidylcholine (36:4)	PC(O-36:4)/LPC(36:4)	in cellulo	640000	[M+H]+	36	4	pos	768.5847	10.73	10.31	11.52	Lyso-PC";" PC-O	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:7) 	PC(38:7)	in cellulo	560000	[M+H]+	38	7	pos	804.5499	8.56	8.26	9.9	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-40:6)	PC(O-40:6)	in cellulo	510000	[M+H]+	40	6	pos	820.6164	10.97	10.52	11.64	PC-O	PC-O";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	510000	[M+Na]+	34	1	pos	782.5605	10.97	10.76	11.28	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:4) 	PC(38:4)	in cellulo	510000	[M+H]+	38	4	pos	810.5961	11.27	10.81	11.59	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:5)	PC(36:5)	in cellulo	500000	[M+H]+	36	5	pos	780.549	8.8	8.04	9.43	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:6)	PC(40:6)	in cellulo	480000	[M+H]+	40	6	pos	834.5973	10.15	9.66	10.83	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (35:1)	PC(35:1)	in cellulo	480000	[M+H]+	35	1	pos	774.5956	11.55	11.08	11.91	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:6) 	PC(40:6)	in cellulo	450000	[M+H]+	40	6	pos	834.5957	11.02	10.76	11.38	PC	PC";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (36:2)	PC(36:2)	in cellulo	450000	[M+Na]+	36	2	pos	808.5762	11.12	10.89	11.6	PC	PC";;;;
"STARD2	START	[M+H]+:  Phosphatidylcholine (O-38:7)	PC(O-38:7)	in cellulo	420000	[M+H]+	38	7	pos	790.5701	10.18	9.2	10.79	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-36:1) 	PC(O-36:1)	in cellulo	380000	[M+H]+	36	1	pos	774.6318	13.38	13	13.94	PC-O	PC-O";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	330000	[M+Na]+	34	2	pos	780.5457	9.89	9.54	10.46	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (31:1)	PC(31:1)	in cellulo	320000	[M+H]+	31	1	pos	718.5341	9.08	8.52	9.62	PC	PC";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	310000	[M+Na]+	32	1	pos	754.53	9.79	9.37	10.16	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-36:5)";" Lysophosphatidylcholine (36:5)	PC(O-36:5)/LPC(36:5)	in cellulo	230000	[M+H]+	36	5	pos	766.5695	10.49	10.14	11.22	Lyso-PC";" PC-O	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-36:5)";" Lysophosphatidylcholine (36:5)	PC(O-36:5)/LPC(36:5)	in cellulo	210000	[M+H]+	36	5	pos	766.5685	9.87	9.41	10.16	Lyso-PC";" PC-O	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (31:0)	PC(31:0)	in cellulo	210000	[M+H]+	31	0	pos	720.5496	9.82	9.58	10.21	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (30:0)	PC(30:0)	in cellulo	210000	[M+H]+	30	0	pos	706.5342	9.38	9.12	9.72	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:6)	PC(36:6)	in cellulo	200000	[M+H]+	36	6	pos	778.5341	8.35	7.73	9.49	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (34:1) => (18:1/16:0)	PC(34:1)	in cellulo	540000	[M+HCOO]-	34	1	neg	804.5667	10.92	10.66	11.27	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in cellulo	460000	[M+HCOO]-	36	2	neg	830.5823	11.09	10.8	11.56	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (32:1) => (16:1/16:0)	PC(32:1)	in cellulo	410000	[M+HCOO]-	32	1	neg	776.5366	9.61	9.28	10.13	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (34:2) => (18:1/16:1)	PC(34:2)	in cellulo	380000	[M+HCOO]-	34	2	neg	802.5512	9.8	9.48	10.38	PC	PC";;;;
"STARD2	START	 [M+HCOO]-: Phosphatidylcholine (32:2) => (16:1/16:1)	PC(32:2)	in cellulo	120000	[M+HCOO]-	32	2	neg	774.5207	8.69	8.28	9.32	PC	PC";;;;
"STARD2	START	[M+HCOO+1x(HCOONa)]-: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	110000	[M+HCOO+1x(HCOONa)]-	34	1	neg	872.5539	10.92	10.67	11.22	PC	PC";;;;
"STARD2	START	[M+HCOO+1x(HCOONa)]-: Phosphatidylcholine (36:2)	PC(36:2)	in cellulo	90000	[M+HCOO+1x(HCOONa)]-	36	2	neg	898.5689	11.07	10.8	11.52	PC	PC";;;;
"STARD2	START	[M+HCOO+2x(HCOONa)]-: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	87000	[M+HCOO+2x(HCOONa)]-	34	1	neg	940.5403	10.92	10.66	11.22	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	85000	[M+HCOO]-	32	1	neg	762.5568	10.65	10.21	11.05	PC-O	PC-O";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (O-34:1)	PC(O-34:1)	in cellulo	77000	[M+HCOO]-	34	1	neg	790.5887	11.83	11.55	12.18	PC-O	PC-O";;;;
"STARD2	START	[M+HCOO+1x(HCOONa)]-: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	76000	[M+HCOO+1x(HCOONa)]-	32	1	neg	844.5222	9.68	9.32	10.04	PC	PC";;;;
"STARD2	START	[M+HCOO+1x(HCOONa)]-: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	76000	[M+HCOO+1x(HCOONa)]-	34	2	neg	870.5377	9.8	9.53	10.3	PC	PC";;;;
"STARD2	START	[M+HCOO+3x(HCOONa)]-: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	62000	[M+HCOO+3x(HCOONa)]-	34	1	neg	1008.5268	10.92	10.67	11.17	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in cellulo	11000000	[M+H]+	36	2	pos	786.5987	10.68	10.29	11.04	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	8700000	[M+H]+	34	2	pos	758.5674	9.42	9	9.9	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	4400000	[M+H]+	34	1	pos	760.5822	10.53	10.2	10.85	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	3800000	[M+H]+	32	1	pos	732.5533	9.25	7.41	11.63	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in cellulo	1700000	[M+H]+	32	2	pos	730.538	8.29	7.83	9.48	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in cellulo	1600000	[M+H]+	36	3	pos	784.5838	9.75	9.33	10.22	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (O-34:1)	PC(O-34:1)	in cellulo	1300000	[M+H]+	34	1	pos	746.6045	11.37	10.98	11.72	PC-O	PC-O";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (O-36:2)	PC(O-36:2)	in cellulo	1100000	[M+H]+	36	2	pos	772.6186	11.48	11.13	11.96	PC-O	PC-O";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in cellulo	910000	[M+H]+	32	1	pos	718.5742	10.07	9.62	10.59	PC-O	PC-O";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (30:1)	PC(30:1)	in cellulo	720000	[M+H]+	30	1	pos	704.5206	8.07	7.12	10.44	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (34:3)	PC(34:3)	in cellulo	680000	[M+H]+	34	3	pos	756.5517	8.59	8.13	9.28	PC	PC";;;;
"STARD10	START	[M+H]+: Lysophosphatidylcholine (38:5)";" Phosphatidylcholine (O-38:5)	PC(O-38:5)/LPC(38:5)	in cellulo	590000	[M+H]+	38	5	pos	794.6041	10.39	9.91	11.52	PC-O";" Lyso-PC	PC-O";;
"STARD10	START	[M+H]+: Phosphatidylcholine (36:4)	PC(36:4)	in cellulo	570000	[M+H]+	36	4	pos	782.5677	8.83	8.38	9.73	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (35:2)	PC(35:2)	in cellulo	450000	[M+H]+	35	2	pos	772.5833	10.02	9.62	10.43	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (38:6)	PC(38:6)	in cellulo	400000	[M+H]+	38	6	pos	806.5692	9.25	8.08	10.01	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (O-40:7)	PC(O-40:7)	in cellulo	340000	[M+H]+	40	7	pos	818.6061	10.1	9.43	10.7	PC-O	PC-O";;;;
"STARD10	START	[M+Na]+: Phosphatidylcholine (36:2)	PC(36:2)	in cellulo	350000	[M+Na]+	36	2	pos	808.5821	10.68	10.33	11	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (40:7)	PC(40:7)	in cellulo	320000	[M+H]+	40	7	pos	832.5849	9.36	8.96	9.64	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (38:4)	PC(38:4)	in cellulo	290000	[M+H]+	38	4	pos	810.6002	10.11	9.54	10.75	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (38:5)	PC(38:5)	in cellulo	270000	[M+H]+	38	5	pos	808.5844	9.62	9.26	9.97	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (O-36:4)";" Lysophosphatidylcholine (36:4)	PC(O-36:4)/LPC(36:4)	in cellulo	250000	[M+H]+	36	4	pos	768.5883	10.29	9.57	11.53	Lyso-PC";" PC-O	PC-O";;
"STARD10	START	[M+H]+: Phosphatidylcholine (33:2)	PC(33:2)	in cellulo	190000	[M+H]+	33	2	pos	744.5533	8.82	8.42	9.32	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in cellulo	180000	[M+H]+	34	2	pos	744.5893	11.15	10.87	11.53	PC-O	PC-O";;;;
"STARD10	START	[M+Na]+: Phosphatidylcholine (34:2)	PC(34:2)	in cellulo	170000	[M+Na]+	34	2	pos	780.5494	9.42	9.04	9.85	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (38:2)	PC(38:2)	in cellulo	160000	[M+H]+	38	2	pos	814.6322	11.99	11.6	12.41	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (38:7)	PC(38:7)	in cellulo	140000	[M+H]+	38	7	pos	804.5533	8.21	7.83	8.58	PC	PC";;;;
"STARD10	START	[M+HCOO]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in cellulo	270000	[M+HCOO]-	36	2	neg	830.5859	10.72	10.48	11	PC	PC";;;;
"STARD10	START	[M+HCOO]-: Phosphatidylcholine (34:1) => (18:1/16:0)	PC(34:1)	in cellulo	100000	[M+HCOO]-	34	1	neg	804.5701	10.57	10.35	10.86	PC	PC";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (O-38:6)	PE(O-38:6)	in cellulo	92000	[M-H]-	38	6	neg	748.5231	10.63	10.23	10.86	PE-O	PE-O";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (O-40:8)	PE(O-40:8)	in cellulo	48000	[M-H]-	40	8	neg	772.5237	10.36	10.06	10.53	PE-O	PE-O";;;;
"STARD11	START	[M+H]+: Ceramide (d34:1) => (d18:1/16:0)	Cer(d34:1)	in cellulo	3000000	[M+H]+	34	1	pos	538.5229	10.4	10.01	10.68	dCer	dCer";;;;
"STARD11	START	[M+Na]+: Ceramide (d*34:1)	Cer(d*34:1)	in cellulo	1700000	[M+Na]+	34	1	pos	560.4967	10.43	10.05	10.62	DHCer";" dCer	d*Cer";;;
"STARD11	START	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in cellulo	610000	[M+H]+	34	1	pos	760.5778	10.31	9.97	11.14	PC	PC";;;;
"STARD11	START	[M+NH4]+: Triacylglycerol (48:3) => (16:1/16:1/16:1) 	TAG(48:3)	in cellulo	600000	[M+NH4]+	48	3	pos	818.7187	18.06	17.86	18.31	TAG	TAG";;;;
"STARD11	START	[M+NH4]+: Triacylglycerol (50:2)	TAG(50:2)	in cellulo	520000	[M+NH4]+	50	2	pos	848.7621	18.43	17.94	19.56	TAG	TAG";;;;
"STARD11	START	[M+H]+: Ceramide (d32:1) => (d18:1/14:0)	Cer(d32:1)	in cellulo	440000	[M+H]+	32	1	pos	510.4906	9.1	8.46	10.7	dCer	dCer";;;;
"STARD11	START	[M+Na]+: Ceramide (d*32:1)	Cer(d*32:1)	in cellulo	340000	[M+Na]+	32	1	pos	532.4736	9.07	8.59	9.22	DHCer";" dCer	d*Cer";;;
"STARD11	START	[M+H]+: Ceramide (d34:2) => (d18:2/16:0)	Cer(d34:2)	in cellulo	260000	[M+H]+	34	2	pos	536.5075	9.3	8.85	9.65	dCer	dCer";;;;
"STARD11	START	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in cellulo	250000	[M+H]+	32	1	pos	732.549	9.03	6.24	10.66	PC	PC";;;;
"STARD11	START	[M+Na]+: Ceramide (d*34:2)	Cer(d*34:2)	in cellulo	240000	[M+Na]+	34	2	pos	558.482	9.3	8.85	9.6	dCer";" DHCer	d*Cer";;;
"STARD11	START	[M+NH4]+: Triacylglycerol (53:2)	TAG(53:2)	in cellulo	170000	[M+NH4]+	53	2	pos	890.8161	19.22	19.1	19.36	TAG	TAG";;;;
"STARD11	START	[M+H]+: Ceramide (DH48:0) => (DH24:0/24:0)	Cer(DH48:0)	in cellulo	160000	[M+H]+	48	0	pos	736.7506	18.36	18.14	18.48	DHCer	DHCer";;;;
"STARD11	START	[M+H]+: Ceramide (DH46:0) => (DH22:0/24:0)	Cer(DH46:0)	in cellulo	150000	[M+H]+	46	0	pos	708.7184	17.89	17.63	18.02	DHCer	DHCer";;;;
"STARD11	START	[M+NH4]+: Triacylglycerol (47:2) => (16:1/16:1/15:0)	TAG(47:2)	in cellulo	150000	[M+NH4]+	47	2	pos	806.7195	17.68	17.27	18.06	TAG	TAG";;;;
"STARD11	START	[M+NH4]+: Triacylglycerol (46:3) => (16:1/16:1/14:1)	TAG(46:3)	in cellulo	140000	[M+NH4]+	46	3	pos	790.6867	17.53	17.31	17.76	TAG	TAG";;;;
"STARD11	START	[M+H]+: Ceramide (d36:1) => (d18:1/18:0)	Cer(d36:1)	in cellulo	140000	[M+H]+	36	1	pos	566.546	11.88	11.57	12.2	dCer	dCer";;;;
"STARD11	START	[M+H]+: Ceramide (d33:1) => (d17:1/16:0)	Cer(d33:1)	in cellulo	130000	[M+H]+	33	1	pos	524.5067	9.73	9.31	10.22	dCer	dCer";;;;
"STARD11	START	[M+H]+: Ceramide (t48:0) => (t22:0/26:0)	Cer(t48:0)	in cellulo	130000	[M+H]+	48	0	pos	752.7428	17.94	17.83	18.14	tCer	tCer";;;;
"STARD11	START	[M+Na]+: Ceramide (t46:0)";" Ceramide (DH46:0-OH)	Cer(DH46:0-OH)/Cer(t46:0)	in cellulo	120000	[M+Na]+	46	0	pos	746.695	17.38	17.23	17.67	DHCer-OH";" tCer	DHOH*Cer";;
"STARD11	START	[M+Na]+: Ceramide (d*33:1)	Cer(d*33:1)	in cellulo	120000	[M+Na]+	33	1	pos	546.4909	9.82	9.27	10.59	DHCer";" dCer	d*Cer";;;
"STARD11	START	[M+Na]+: Ceramide (DH46:0)	Cer(DH46:0)	in cellulo	110000	[M+Na]+	46	0	pos	730.7005	17.88	17.63	17.98	DHCer	DHCer";;;;
"STARD11	START	[M+Na]+: Ceramide (t48:0)";" Ceramide (DH48:0-OH)	Cer(DH48:0-OH)/Cer(t48:0)	in cellulo	110000	[M+Na]+	48	0	pos	774.7255	17.95	17.83	18.14	DHCer-OH";" tCer	DHOH*Cer";;
"STARD11	START	[M+HCOO]-: Ceramide (d34:1) => (d18:1/16:0)	Cer(d34:1)	in cellulo	1200000	[M+HCOO]-	34	1	neg	582.5033	10.42	10.14	10.6	dCer	dCer";;;;
"STARD11	START	[M+HCOO]-: Ceramide (d32:1) => (d18:1/14:0)	Cer(d32:1)	in cellulo	130000	[M+HCOO]-	32	1	neg	554.4725	9.05	8.7	9.21	dCer	dCer";;;;
"CRABP2	lipocalin	[M-H]-: heptadecenoate => (17:1)	FA(17:1)	in vitro	49000	[M-H]-	17	1	neg	267.2327	3.54	2.81	3.66	FA	FA";;;;
"FABP1	lipocalin	[M+H]+: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	1900000	[M+H]+	17	1	pos	466.2935	1.95	0.15	2.12	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M+H]+: Lysophosphatidylethanolamine (18:1) => (18:1)	LPE(18:1)	in vitro	610000	[M+H]+	18	1	pos	480.3089	2.29	0.18	2.47	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M+H]+: Lysophosphatidylethanolamine (16:1) => (16:1)	LPE(16:1)	in vitro	520000	[M+H]+	16	1	pos	452.2771	1.43	0.84	1.61	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M+NH4]+: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	190000	[M+NH4]+	34	1	pos	766.5601	7.78	6.72	8.13	PG	PG";;;;
"FABP1	lipocalin	[M+NH4]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	180000	[M+NH4]+	36	2	pos	792.5752	7.95	6.99	8.48	PG	PG";;;;
"FABP1	lipocalin	[M+NH4]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	160000	[M+NH4]+	32	1	pos	738.5293	6.66	5.38	6.95	PG	PG";;;;
"FABP1	lipocalin	[M+NH4]+: Phosphatidylglycerol (34:2) => (18:1/16:1)	PG(34:2)	in vitro	130000	[M+NH4]+	34	2	pos	764.5445	6.77	5.56	7.21	PG	PG";;;;
"FABP1	lipocalin	[M+Na]+: Lysophosphatidylethanolamine (17:1)	LPE(17:1)	in vitro	120000	[M+Na]+	17	1	pos	488.275	1.95	1.06	2.11	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M+H]+: Lysophosphatidylcholine (18:1)";"Phosphatidylcholine (O-18:1)	PC(O-18:1)/LPC(18:1)	in vitro	100000	[M+H]+	18	1	pos	522.3565	2.23	1.27	2.6	PC-O";" Lyso-PC	LPC";;
"FABP1	lipocalin	[M+NH4]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	100000	[M+NH4]+	33	1	pos	752.5443	7.41	6.32	7.66	PG	PG";;;;
"FABP1	lipocalin	[M+NH4]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	74000	[M+NH4]+	35	2	pos	778.56	7.53	6.5	7.83	PG	PG";;;;
"FABP1	lipocalin	[M+H]+: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	63000	[M+H]+	32	2	pos	688.4926	6.57	6	6.99	PE	PE";;;;
"FABP1	lipocalin	[M+H]+: Phosphatidylethanolamine (33:2)	PE(33:2)	in vitro	63000	[M+H]+	33	2	pos	702.5076	7.37	6.85	7.65	PE	PE";;;;
"FABP1	lipocalin	[M+H]+: Phosphatidylethanolamine (30:1) => (14:0/16:1)	PE(30:1)	in vitro	32000	[M+H]+	30	1	pos	662.4767	6.36	5.83	6.68	PE	PE";;;;
"FABP1	lipocalin	[M+H]+: Lysophosphatidylglycerol (18:1)	LPG(18:1)	in vitro	32000	[M+H]+	18	1	pos	511.3037	2	1.44	2.16	Lyso-PG	LPG";;;;
"FABP1	lipocalin	[M+Na]+: Lysophosphatidylethanolamine (16:1)	LPE(16:1)	in vitro	31000	[M+Na]+	16	1	pos	474.2591	1.44	0.76	1.57	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M+H]+: Lysophosphatidylglycerol (16:1) => (16:1)	LPG(16:1)	in vitro	17000	[M+H]+	16	1	pos	483.2714	1.19	0.54	1.32	Lyso-PG	LPG";;;;
"FABP1	lipocalin	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	13000000	[M-H]-	18	1	neg	281.248	3.77	0.44	8.78	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	3200000	[M-H]-	16	1	neg	253.2169	3.02	0.17	8.01	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: heptadecenoate => (17:1)	FA(17:1)	in vitro	3100000	[M-H]-	17	1	neg	267.2326	3.51	2.65	8.5	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	1100000	[M-H]-	17	1	neg	464.2774	1.97	0.15	2.11	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M+HCOO]-: octadecenoate => (18:1)	FA(18:1)	in vitro	960000	[M+HCOO]-	18	1	neg	327.2533	3.74	1.42	8.69	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: eicosatetraenoate => (20:4)	FA(20:4)	in vitro	380000	[M-H]-	20	4	neg	303.2321	3.17	2.17	3.31	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: nonadecenoate => (19:1)	FA(19:1)	in vitro	350000	[M-H]-	19	1	neg	295.2638	4.32	3.64	4.49	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: Lysophosphatidylethanolamine (16:1) => (16:1)	LPE(16:1)	in vitro	350000	[M-H]-	16	1	neg	450.2622	1.44	0.15	1.58	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M-H]-: Lysophosphatidylethanolamine (18:1) => (18:1)	LPE(18:1)	in vitro	310000	[M-H]-	18	1	neg	478.2934	2.3	0.17	2.44	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M-H]-: Lysophosphatidylethanolamine (16:0) => (16:0)	LPE(16:0)	in vitro	140000	[M-H]-	16	0	neg	452.2775	2.15	1.16	2.31	Lyso-PE	LPE";;;;
"FABP1	lipocalin	[M+HCOO]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	140000	[M+HCOO]-	16	1	neg	299.2221	3.02	1.49	3.81	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	110000	[M-H]-	34	1	neg	747.5198	7.84	6.41	8.12	PG	PG";;;;
"FABP1	lipocalin	[M-H]-: octadecadienoate => (18:2)	FA(18:2)	in vitro	93000	[M-H]-	18	2	neg	279.2322	3.26	2.1	3.6	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	86000	[M-H]-	32	1	neg	719.4886	6.66	4.98	6.92	PG	PG";;;;
"FABP1	lipocalin	[M-H]-: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	69000	[M-H]-	34	2	neg	745.505	6.77	5.11	7.2	PG	PG";;;;
"FABP1	lipocalin	[M-H]-: docosapentaenoate => (22:5)	FA(22:5)	in vitro	62000	[M-H]-	22	5	neg	329.2478	3.3	2.56	3.58	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: eicosatrienoate => (20:3)	FA(20:3)	in vitro	61000	[M-H]-	20	3	neg	305.2478	3.49	2.85	3.69	FA	FA";;;;
"FABP1	lipocalin	[M-H]-: Phosphatidylglycerol (33:1) => (17:1/16:0)	PG(33:1)	in vitro	60000	[M-H]-	33	1	neg	733.5043	7.4	5.9	7.67	PG	PG";;;;
"FABP1	lipocalin	[M-H]-: Phosphatidylglycerol (35:2) => (17:1/18:1)	PG(35:2)	in vitro	41000	[M-H]-	35	2	neg	759.5197	7.52	6.05	7.81	PG	PG";;;;
"FABP1	lipocalin	[M-H]-: Lysophosphatidylglycerol (16:1) => (16:1)	LPG(16:1)	in vitro	24000	[M-H]-	16	1	neg	481.2561	1.15	0.76	1.34	Lyso-PG	LPG";;;;
"FABP1	lipocalin	[M-H]-: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	19000	[M-H]-	32	2	neg	686.4782	6.59	5.99	6.92	PE	PE";;;;
"FABP1	lipocalin	[M-H]-: Phosphatidylethanolamine (33:2) => (17:1/16:1)	PE(33:2)	in vitro	19000	[M-H]-	33	2	neg	700.4937	7.37	6.85	7.68	PE	PE";;;;
"FABP5	lipocalin	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	1600000	[M-H]-	18	1	neg	281.249	3.79	2.93	8.8	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	1500000	[M-H]-	16	1	neg	253.2173	3.03	2.08	8.01	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: eicosatetraenoate => (20:4)	FA(20:4)	in vitro	250000	[M-H]-	20	4	neg	303.2336	3.17	2.28	3.4	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: heptadecenoate => (17:1)	FA(17:1)	in vitro	170000	[M-H]-	17	1	neg	267.2332	3.52	2.76	3.67	FA	FA";;;;
"FABP5	lipocalin	[M+HCOO]-: octadecenoate => (18:1)	FA(18:1)	in vitro	170000	[M+HCOO]-	18	1	neg	327.2544	3.71	2.07	4.69	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: octadecadienoate => (18:2)	FA(18:2)	in vitro	46000	[M-H]-	18	2	neg	279.2333	3.26	2.37	3.53	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: docosapentaenoate => (22:5)	FA(22:5)	in vitro	34000	[M-H]-	22	5	neg	329.249	3.31	2.48	3.58	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: eicosatrienoate => (20:3)	FA(20:3)	in vitro	27000	[M-H]-	20	3	neg	305.2488	3.49	3.12	3.67	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: eicosapentaenoate => (20:5)	FA(20:5)	in vitro	26000	[M-H]-	20	5	neg	301.2175	2.68	1.86	2.89	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: nonadecenoate => (19:1)	FA(19:1)	in vitro	17000	[M-H]-	19	1	neg	295.2645	4.32	3.75	4.45	FA	FA";;;;
"FABP5	lipocalin	[M-H]-: docosatetraenoate => (22:4)	FA(22:4)	in vitro	13000	[M-H]-	22	4	neg	331.2644	3.75	3.02	3.9	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	3200000	[M-H]-	18	1	neg	281.2486	3.78	2.86	8.79	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	1900000	[M-H]-	16	1	neg	253.2173	3.03	2.02	4.58	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: eicosatetraenoate => (20:4)	FA(20:4)	in vitro	880000	[M-H]-	20	4	neg	303.2333	3.16	2.2	3.38	FA	FA";;;;
"FABP7	lipocalin	[M+HCOO]-: octadecenoate => (18:1)	FA(18:1)	in vitro	310000	[M+HCOO]-	18	1	neg	327.2542	3.7	1.95	8.65	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: heptadecenoate => (17:1)	FA(17:1)	in vitro	170000	[M-H]-	17	1	neg	267.2329	3.5	2.69	3.67	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: docosapentaenoate => (22:5)	FA(22:5)	in vitro	140000	[M-H]-	22	5	neg	329.2487	3.31	2.43	3.62	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: octadecadienoate => (18:2)	FA(18:2)	in vitro	100000	[M-H]-	18	2	neg	279.2331	3.25	2.32	3.54	FA	FA";;;;
"FABP7	lipocalin	[M+HCOO]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	63000	[M+HCOO]-	16	1	neg	299.2226	3.02	1.88	3.79	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: nonadecenoate => (19:1)	FA(19:1)	in vitro	54000	[M-H]-	19	1	neg	295.2645	4.31	3.71	4.45	FA	FA";;;;
"FABP7	lipocalin	[M-H]-: eicosapentaenoate => (20:5)	FA(20:5)	in vitro	52000	[M-H]-	20	5	neg	301.2176	2.76	1.8	2.89	FA	FA";;;;
"GLTP	GLTP	[M+NH4]+: docosatrienoate => (22:3)	FA(22:3)	in vitro	1700000	[M+NH4]+	22	3	pos	352.3211	2.58	0.75	7.63	FA	FA";;;;
"GLTP	GLTP	[M+NH4]+: octadecatrienol => (18:3)	FAL(18:3)	in vitro	1600000	[M+NH4]+	18	3	pos	282.2788	2.96	1.7	8.08	FAL	FAL";;;;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d42:2)";"Hexosyl ceramide (DH42:2)	HexCer(d*42:2)	in vitro	590000	[M+H]+	42	2	pos	810.6816	11.92	11.7	12.36	Hex-DHCer"; Hex-dCer;" Hex-dCer	d*HexCer";
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t42:2)";"Hexosyl ceramide (d42:2-OH)	HexCer(t*42:2)	in vitro	390000	[M+H]+	42	2	pos	826.6767	11.53	11.29	11.96	Hex-DHCer-OH"; Hex-tCer; Hex-dCer-OH;" Hex-dCer-OH	t*HexCer"
"GLTP	GLTP	[M+NH4]+: octadecatrienoate => (18:3)	FA(18:3)	in vitro	220000	[M+NH4]+	18	3	pos	296.2586	1.19	0.17	1.51	FA	FA";;;;
"GLTP	GLTP	[M+H]+: Phosphatidylethanolamine (O-16:0)";"Lysophosphatidylethanolamine (16:0)	PE(O-16:0)/LPE(16:0)	in vitro	160000	[M+H]+	16	0	pos	454.2933	2.19	1.31	2.55	Lyso-PE";" PE-O	LPE";;
"GLTP	GLTP	[M+NH4]+: docosatetraenoate => (22:4)	FA(22:4)	in vitro	120000	[M+NH4]+	22	4	pos	350.3053	2.38	0.32	3.82	FA	FA";;;;
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (d42:2)";"Hexosyl ceramide (DH42:2)	HexCer(d*42:2)	in vitro	110000	[M+Na]+	42	2	pos	832.6635	11.9	11.7	12.2	Hex-DHCer";" Hex-dCer	d*HexCer";;
"GLTP	GLTP	[M+H]+: Sulfohexosyl ceramide (d42:2)";"Sulfohexosyl ceramide (DH42:2)	SHexCer(d*42:2)	in vitro	93000	[M+H]+	42	2	pos	890.6388	9.89	9.59	10.2	SHex-dCer"; SHex-dCer;" SHex-DHCer	d*SHexCer";
"GLTP	GLTP	[M+Na]+: Hexosyl ceramide (t42:2)";"Hexosyl ceramide (d42:2-OH)	HexCer(t*42:2)	in vitro	65000	[M+Na]+	42	2	pos	848.6584	11.51	11.29	11.8	Hex-DHCer-OH"; Hex-tCer;" Hex-dCer-OH	t*HexCer";
"GLTP	GLTP	[M+H]+: Lysophosphatidylethanolamine (16:1)";"Phosphatidylethanolamine (O-16:1)	PE(O-16:1)/LPE(16:1)	in vitro	59000	[M+H]+	16	1	pos	452.2775	1.47	0.48	2.36	Lyso-PE";" PE-O	LPE";;
"GLTP	GLTP	[M+H]+: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	58000	[M+H]+	17	1	pos	466.2931	1.99	1.16	2.37	Lyso-PE	LPE";;;;
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t42:1)";"Hexosyl ceramide (d42:1-OH)	HexCer(t*42:1)	in vitro	57000	[M+H]+	42	1	pos	828.6929	12.92	12.65	13.25	Hex-DHCer-OH"; Hex-tCer; Hex-dCer-OH;" Hex-dCer-OH	t*HexCer"
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (d42:1)";"Hexosyl ceramide (DH42:1)	HexCer(d*42:1)	in vitro	51000	[M+H]+	42	1	pos	812.6978	13.33	12.99	13.71	Hex-dCer"; Hex-dCer;" Hex-DHCer	d*HexCer";
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t40:2)";"Hexosyl ceramide (d40:2-OH)	HexCer(t*40:2)	in vitro	45000	[M+H]+	40	2	pos	798.6445	10.01	8.9	10.71	Hex-tCer"; Hex-dCer-OH; Hex-DHCer-OH;" Hex-dCer-OH	t*HexCer"
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t44:2)";"Hexosyl ceramide (d44:2-OH)	HexCer(t*44:2)	in vitro	40000	[M+H]+	44	2	pos	854.7082	12.86	12.31	13.27	Hex-dCer-OH"; Hex-dCer-OH; Hex-DHCer-OH;" Hex-tCer	t*HexCer"
"GLTP	GLTP	[M+H]+: Hexosyl ceramide (t40:1)";"Hexosyl ceramide (d40:1-OH)	HexCer(t*40:1)	in vitro	39000	[M+H]+	40	1	pos	800.6605	11.53	11.31	11.8	Hex-dCer-OH"; Hex-dCer-OH; Hex-DHCer-OH;" Hex-tCer	t*HexCer"
"GLTP	GLTP	[M+H]+: Lysophosphatidylglycerol (18:1)	LPG(18:1)	in vitro	31000	[M+H]+	18	1	pos	511.3034	1.98	1.48	2.14	Lyso-PG	LPG";;;;
"GLTP	GLTP	[M+H]+: Lysophosphatidylethanolamine (16:1)";"Phosphatidylethanolamine (O-16:1)	PE(O-16:1)/LPE(16:1)	in vitro	11000	[M+H]+	16	1	pos	452.2772	1.95	1.84	2.14	Lyso-PE";" PE-O	LPE";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d42:2) => (d18:1/24:1)";"Hexosyl ceramide (DH42:2) => (DH18:1/24:1)	HexCer(d*42:2)	in vitro	170000	[M+HCOO]-	42	2	neg	854.6749	11.93	11.74	12.27	Hex-DHCer";" Hex-dCer	d*HexCer";;
"GLTP	GLTP	[M-H]-: Sulfohexosyl ceramide (d42:2)";"Sulfohexosyl ceramide (DH42:2)	SHexCer(d*42:2)	in vitro	100000	[M-H]-	42	2	neg	888.6263	9.9	9.69	10.22	SHex-dCer";" SHex-DHCer	d*SHexCer";;
"GLTP	GLTP	[M-H]-: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	41000	[M-H]-	17	1	neg	464.2786	2	1.19	2.14	Lyso-PE	LPE";;;;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d42:1)";"Hexosyl ceramide (DH42:1)	HexCer(d*42:1)	in vitro	27000	[M+HCOO]-	42	1	neg	856.6907	12.59	12.28	13.5	Hex-dCer";" Hex-DHCer	d*HexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (t42:1)";"Hexosyl ceramide (d42:1-OH)	HexCer(t*42:1)	in vitro	18000	[M+HCOO]-	42	1	neg	872.6853	12.59	11.84	13.22	Hex-DHCer-OH"; Hex-tCer;" Hex-dCer-OH	t*HexCer";
"GLTP	GLTP	[M-H]-: Sulfohexosyl ceramide (d42:1)";"Sulfohexosyl ceramide (DH42:1)	SHexCer(d*42:1)	in vitro	14000	[M-H]-	42	1	neg	890.6419	10.39	10.22	10.66	SHex-DHCer";" SHex-dCer	d*SHexCer";;
"GLTP	GLTP	[M+HCOO]-: Hexosyl ceramide (d42:1) => (d18:1/24:0)";"Hexosyl ceramide (DH42:1) => (DH18:1/24:0)	HexCer(d*42:1)	in vitro	13000	[M+HCOO]-	42	1	neg	856.6909	13.2	12.29	13.62	Hex-DHCer";" Hex-dCer	d*HexCer";;
"GLTP	GLTP	[M-H]-: Lysophosphatidylethanolamine (O-18:1)	LPE(O-18:1)	in vitro	13000	[M-H]-	18	1	neg	464.3152	3.4	3.04	3.56	Lyso-PE-O	LPE-O";;;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d34:1)";"Sphingomyelin (DH34:1)	SM(d*34:1)	in vitro	1400000	[M+H]+	34	1	pos	703.5754	7.03	6.69	7.41	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d42:2)";"Sphingomyelin (DH42:2)	SM(d*42:2)	in vitro	1000000	[M+H]+	42	2	pos	813.6844	11.34	11.11	12.03	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d40:1)";"Sphingomyelin (DH40:1)	SM(d*40:1)	in vitro	440000	[M+H]+	40	1	pos	787.6689	11.39	11.1	11.88	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d40:2)";"Sphingomyelin (DH40:2)	SM(d*40:2)	in vitro	370000	[M+H]+	40	2	pos	785.6536	9.96	9.72	10.58	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (DH34:0)	SM(DH34:0)	in vitro	170000	[M+H]+	34	0	pos	705.5904	7.58	7.29	7.95	DHSM	DHSM";;;;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d42:1)";"Sphingomyelin (DH42:1)	SM(d*42:1)	in vitro	160000	[M+H]+	42	1	pos	815.7003	11.92	11.64	13.49	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d36:2)";"Sphingomyelin (DH36:2)	SM(d*36:2)	in vitro	140000	[M+H]+	36	2	pos	729.5914	7.33	7.04	7.86	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d42:3)";"Sphingomyelin (DH42:3)	SM(d*42:3)	in vitro	140000	[M+H]+	42	3	pos	811.669	10.25	10.02	10.87	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d35:1)";"Sphingomyelin (DH35:1)	SM(d*35:1)	in vitro	140000	[M+H]+	35	1	pos	717.5903	7.67	7.17	8.07	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d33:1)";"Sphingomyelin (DH33:1)	SM(d*33:1)	in vitro	110000	[M+H]+	33	1	pos	689.5596	6.39	6.06	6.67	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d41:2)";"Sphingomyelin (DH41:2)	SM(d*41:2)	in vitro	100000	[M+H]+	41	2	pos	799.6701	10.66	10.42	11.54	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d38:1)";"Sphingomyelin (DH38:1)	SM(d*38:1)	in vitro	100000	[M+H]+	38	1	pos	759.6378	9.93	9.03	10.4	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d40:1)";"Sphingomyelin (DH40:1)	SM(d*40:1)	in vitro	90000	[M+H]+	40	1	pos	787.6691	10.54	10.22	12.1	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d39:1)";"Sphingomyelin (DH39:1)	SM(d*39:1)	in vitro	59000	[M+H]+	39	1	pos	773.6537	10.73	10.29	11.17	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+H]+: Sphingomyelin (d34:2)";"Sphingomyelin (DH34:2)	SM(d*34:2)	in vitro	51000	[M+H]+	34	2	pos	701.5607	6.03	5.66	7.03	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+Na]+: Sphingomyelin (d34:1)";"Sphingomyelin (DH34:1)	SM(d*34:1)	in vitro	34000	[M+Na]+	34	1	pos	725.5569	7.01	6.74	7.33	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d34:1)";"Sphingomyelin (DH34:1)	SM(d*34:1)	in vitro	120000	[M+HCOO]-	34	1	neg	747.5677	7.03	6.75	7.37	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d42:2)";"Sphingomyelin (DH42:2)	SM(d*42:2)	in vitro	49000	[M+HCOO]-	42	2	neg	857.6781	11.35	11.15	12.02	dSM";" DHSM	d*SM";;
"GLTPD1	GLTP	[M-H]-: Bismonoacylglycerolphosphate (30:1)";"Phosphatidylglycerol (30:1) => (16:1/14:0)	PG/BMP(30:1)	in vitro	46000	[M-H]-	30	1	neg	691.4571	5.31	4.88	5.53	BMP";" PG	PG/BMP";;
"GLTPD1	GLTP	[M-H]-: Bismonoacylglycerolphosphate (32:2)";"Phosphatidylglycerol (32:2) => (16:1/16:1)	PG/BMP(32:2)	in vitro	35000	[M-H]-	32	2	neg	717.4732	5.49	5.15	5.69	PG";" BMP	PG/BMP";;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d40:1)";"Sphingomyelin (DH40:1)	SM(d*40:1)	in vitro	24000	[M+HCOO]-	40	1	neg	831.6622	11.4	11.12	11.89	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d36:1)";"Sphingomyelin (DH36:1)	SM(d*36:1)	in vitro	22000	[M+HCOO]-	36	1	neg	775.5987	8.44	8.17	8.79	DHSM";" dSM	d*SM";;
"GLTPD1	GLTP	[M+HCOO]-: Sphingomyelin (d40:2)";"Sphingomyelin (DH40:2)	SM(d*40:2)	in vitro	21000	[M+HCOO]-	40	2	neg	829.6462	9.98	9.78	10.62	dSM";" DHSM	d*SM";;
"HSDL2	scp2	[M+NH4]+: Triacylglycerol (54:2) => (18:1/18:1/18:0)	TAG(54:2)	in vitro	260000	[M+NH4]+	54	2	pos	904.8336	17.56	16.7	21.05	TAG	TAG";;;;
"HSDL2	scp2	[M+NH4]+: docosatrienoate => (22:3)	FA(22:3)	in vitro	110000	[M+NH4]+	22	3	pos	352.321	3.01	1.25	8.44	FA	FA";;;;
"HSDL2	scp2	[M+NH4]+: Triacylglycerol (32:0) => (12:0/12:0/8:0)	TAG(32:0)	in vitro	100000	[M+NH4]+	32	0	pos	600.5203	10.67	7.05	15.71	TAG	TAG";;;;
"HSDL2	scp2	[M+NH4]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	81000	[M+NH4]+	32	1	pos	738.5258	6.72	5.78	10.89	PG	PG";;;;
"HSDL2	scp2	[M+H]+: Triacylglycerol (56:5)	TAG(56:5)	in vitro	18000	[M+H]+	56	5	pos	909.789	17.38	17.07	17.68	TAG	TAG";;;;
"LCN15	lipocalin	[M+NH4]+: Phosphatidylglycerol (32:2) => 16:1/16:1)	PG(32:2)	in vitro	44000	[M+NH4]+	32	2	pos	736.5123	5.65	4.59	5.93	PG	PG";;;;
"LCN15	lipocalin	[M-H]-: Phosphatidylglycerol (32:1)";"Bismonoacylglycerolphosphate (32:1) => (16:1/16:0)	PG/BMP(32:1)	in vitro	160000	[M-H]-	32	1	neg	719.4862	6.6	5.52	6.84	PG";" BMP	PG/BMP";;
"LCN15	lipocalin	[M-H]-: Phosphatidylglycerol (34:2)";"Bismonoacylglycerolphosphate (34:2) => (16:1/18:1)	PG/BMP(34:2)	in vitro	150000	[M-H]-	34	2	neg	745.5018	6.7	5.67	7.06	PG";" BMP	PG/BMP";;
"LCN15	lipocalin	[M-H]-: Phosphatidylglycerol (33:1)";"Bismonoacylglycerolphosphate (33:1) => (17:1/16:0)	PG/BMP(33:1)	in vitro	51000	[M-H]-	33	1	neg	733.5015	7.33	6.38	7.59	PG";" BMP	PG/BMP";;
"LCN15	lipocalin	[M-H]-: Bismonoacylglycerolphosphate (35:2)";"Phosphatidylglycerol (35:2) => (17:1/18:1)	PG/BMP(35:2)	in vitro	45000	[M-H]-	35	2	neg	759.5164	7.45	6.53	7.73	BMP";" PG	PG/BMP";;
"LCN15	lipocalin	[M-H]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	26000	[M-H]-	32	2	neg	717.4709	5.63	4.37	5.88	PG	PG";;;;
"OSBPL5	OSBP	[M-H]-: Phosphatidylethanolamine (33:1) => (17:1/16:0)	PE(33:1)	in vitro	84000	[M-H]-	33	1	neg	702.5104	8.51	8.08	8.84	PE	PE";;;;
"OSBPL5	OSBP	[M-H]-: Phosphatidylethanolamine (36:2)  => (18:1/18:1)	PE(36:2)	in vitro	63000	[M-H]-	36	2	neg	742.5423	9.12	8.73	9.64	PE	PE";;;;
"OSBPL5	OSBP	[M-H]-: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	40000	[M-H]-	34	2	neg	714.5105	7.82	7.33	8.3	PE	PE";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	72000000	[M+H]+	36	2	pos	786.5989	8.98	8.35	9.7	PC	PC";;;;
"PITPNA	IP_trans	[M+Na]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	3400000	[M+Na]+	36	2	pos	808.5797	8.99	8.59	9.38	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in vitro	3000000	[M+H]+	34	1	pos	760.5834	8.76	8.31	9.44	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (34:2)	PC(34:2)	in vitro	1400000	[M+H]+	34	2	pos	758.5681	7.74	7.17	8.39	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (38:3)	PC(38:3)	in vitro	770000	[M+H]+	38	3	pos	812.6141	9.66	9.31	10.26	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in vitro	720000	[M+H]+	36	3	pos	784.5838	8.02	7.44	8.88	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in vitro	600000	[M+H]+	32	1	pos	732.5526	7.44	6.93	8.12	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (36:4)	PC(36:4)	in vitro	410000	[M+H]+	36	4	pos	782.5681	7.69	6.57	8.68	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (38:5)	PC(38:5)	in vitro	380000	[M+H]+	38	5	pos	808.5816	7.81	7.1	9.79	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (32:0)	PC(32:0)	in vitro	230000	[M+H]+	32	0	pos	734.5684	8.55	8.16	8.88	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in vitro	150000	[M+H]+	33	1	pos	746.5681	8.09	7.32	11.3	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (34:3)	PC(34:3)	in vitro	150000	[M+H]+	34	3	pos	756.5535	6.9	6.27	7.61	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (35:1)	PC(35:1)	in vitro	130000	[M+H]+	35	1	pos	774.5982	9.41	8.39	12.39	PC	PC";;;;
"PITPNA	IP_trans	[M+NH4]+: Phosphatidylinositol (38:4) => (18:0/20:4)	PI(38:4)	in vitro	65000	[M+NH4]+	38	4	pos	904.5889	7.92	7.15	8.2	PI	PI";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in vitro	59000	[M+H]+	32	2	pos	730.5371	6.32	5.84	8.51	PC	PC";;;;
"PITPNA	IP_trans	[M+Na]+: Phosphatidylcholine (34:1)	PC(34:1)	in vitro	48000	[M+Na]+	34	1	pos	782.5649	8.73	8.42	9.07	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (34:0)	PC(34:0)	in vitro	39000	[M+H]+	34	0	pos	762.5995	10	9.62	10.4	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (36:5)	PC(36:5)	in vitro	24000	[M+H]+	36	5	pos	780.5517	6.83	5.89	6.98	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (38:4)	PC(38:4)	in vitro	23000	[M+H]+	38	4	pos	810.597	10.25	9.96	10.72	PC	PC";;;;
"PITPNA	IP_trans	[M+H]+: Phosphatidylcholine (30:0)	PC(30:0)	in vitro	22000	[M+H]+	30	0	pos	706.5375	7.14	6.48	7.74	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in vitro	4700000	[M+HCOO]-	36	2	neg	830.5908	8.97	8.61	9.4	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (34:1) => (18:1/16:0)	PC(34:1)	in vitro	210000	[M+HCOO]-	34	1	neg	804.575	8.76	8.37	9.2	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO+1x(HCOONa)]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in vitro	120000	[M+HCOO+1x(HCOONa)]-	36	2	neg	898.577	8.97	8.62	9.4	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (34:2) => (18:2/16:0)	PC(34:2)	in vitro	100000	[M+HCOO]-	34	2	neg	802.5595	7.75	7.27	8.21	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (38:4) => (20:4/18:0)	PC(38:4)	in vitro	61000	[M+HCOO]-	38	4	neg	854.5903	9.12	8.25	9.51	PC	PC";;;;
"PITPNA	IP_trans	[M-H]-: Phosphatidylinositol (38:4) => (18:0/20:4)	PI(38:4)	in vitro	61000	[M-H]-	38	4	neg	885.5482	7.91	7.09	8.21	PI	PI";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (32:1) =>(16:1/16:0)	PC(32:1)	in vitro	55000	[M+HCOO]-	32	1	neg	776.5438	7.42	6.98	8.22	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (36:3) =>(18:2/18:1)	PC(36:3)	in vitro	48000	[M+HCOO]-	36	3	neg	828.5739	7.95	7.34	8.76	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (36:1) => (18:1/18:0)	PC(36:1)	in vitro	42000	[M+HCOO]-	36	1	neg	832.6076	10.21	9.86	10.62	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (38:3) => (20:3/18:0)	PC(38:3)	in vitro	38000	[M+HCOO]-	38	3	neg	856.6068	9.63	9.31	10.06	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO+2x(HCOONa)]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in vitro	34000	[M+HCOO+2x(HCOONa)]-	36	2	neg	966.5647	8.97	8.62	9.47	PC	PC";;;;
"PITPNA	IP_trans	[M+HCOO]-: Phosphatidylcholine (36:4) => (20:4/16:0)	PC(36:4)	in vitro	26000	[M+HCOO]-	36	4	neg	826.5595	7.68	7.17	8	PC	PC";;;;
"PITPNA	IP_trans	[M-H]-: Phosphatidylinositol (36:2) => (18:2/18:0)	PI(36:2)	in vitro	21000	[M-H]-	36	2	neg	861.5484	7.97	7.2	8.26	PI	PI";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	55000000	[M+H]+	36	2	pos	786.599	8.98	8.12	10.71	PC	PC";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	16000000	[M+NH4]+	36	2	pos	792.5746	7.95	7.62	8.27	PG	PG";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	7700000	[M+NH4]+	34	2	pos	764.5438	6.78	6.33	7.18	PG	PG";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	3400000	[M+NH4]+	35	2	pos	778.5593	7.52	7.13	7.84	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in vitro	2600000	[M+H]+	34	1	pos	760.5845	8.79	8.49	9.26	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (38:4)	PC(38:4)	in vitro	1600000	[M+H]+	38	4	pos	810.5983	9.14	8.67	9.43	PC	PC";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	1400000	[M+NH4]+	33	1	pos	752.5439	7.4	7	7.71	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	1300000	[M+H]+	36	2	pos	775.5477	7.95	7.58	8.23	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (38:3)	PC(38:3)	in vitro	1200000	[M+H]+	38	3	pos	812.615	9.66	9.41	10.13	PC	PC";;;;
"PITPNB	IP_trans	[M+Na]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	1200000	[M+Na]+	36	2	pos	797.529	7.96	7.58	8.27	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (36:1)	PC(36:1)	in vitro	970000	[M+H]+	36	1	pos	788.6166	10.25	9.98	10.71	PC	PC";;;;
"PITPNB	IP_trans	[M+Na]+: Phosphatidylglycerol (34:2) => (18:1/16:1)	PG(34:2)	in vitro	720000	[M+Na]+	34	2	pos	769.4984	6.78	6.35	7.14	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	620000	[M+H]+	34	2	pos	747.5171	6.78	6.35	7.13	PG	PG";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (37:2) => (18:1/19:1)	PG(37:2)	in vitro	480000	[M+NH4]+	37	2	pos	806.5892	8.83	8.49	9.1	PG	PG";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylinositol (38:4) => (18:0/20:4)	PI(38:4)	in vitro	420000	[M+NH4]+	38	4	pos	904.5898	7.89	7.5	8.1	PI	PI";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	390000	[M+H]+	34	1	pos	749.5323	7.84	7.45	8.1	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	330000	[M+H]+	35	2	pos	761.5317	7.53	7.16	7.76	PG	PG";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (36:3) => (18:2/18:1)	PG(36:3)	in vitro	250000	[M+NH4]+	36	3	pos	790.5589	7.59	7.2	7.88	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (35:2)	PC(35:2)	in vitro	200000	[M+H]+	35	2	pos	772.5883	8.46	7.18	10.33	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	170000	[M+H]+	33	1	pos	735.5183	7.5	7.02	8.38	PG	PG";;;;
"PITPNB	IP_trans	[M+Na]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	160000	[M+Na]+	33	1	pos	757.4991	7.4	7.02	7.67	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (34:3)	PC(34:3)	in vitro	160000	[M+H]+	34	3	pos	756.5537	6.75	6.39	7.67	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (32:0)	PC(32:0)	in vitro	140000	[M+H]+	32	0	pos	734.5697	8.57	8.3	8.87	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (35:1)	PC(35:1)	in vitro	130000	[M+H]+	35	1	pos	774.5988	9.52	9.02	10.28	PC	PC";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (36:1) => (18:1/18:0)	PG(36:1)	in vitro	130000	[M+NH4]+	36	1	pos	794.5886	9.17	8.88	9.41	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (40:4)	PC(40:4)	in vitro	110000	[M+H]+	40	4	pos	838.6334	10.16	9.89	10.48	PC	PC";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (37:4)	PC(37:4)	in vitro	64000	[M+H]+	37	4	pos	796.5861	8.39	7.68	8.79	PC	PC";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (30:0) => (14:0/16:0)	PG(30:0)	in vitro	58000	[M+NH4]+	30	0	pos	712.5121	6.45	6.06	6.64	PG	PG";;;;
"PITPNB	IP_trans	[M+NH4]+: Phosphatidylglycerol (34:3) => (18:2/16:1)	PG(34:3)	in vitro	47000	[M+NH4]+	34	3	pos	762.528	6.42	5.95	6.64	PG	PG";;;;
"PITPNB	IP_trans	[M+H]+: Phosphatidylcholine (38:4)	PC(38:4)	in vitro	19000	[M+H]+	38	4	pos	810.5985	10.23	9.98	10.55	PC	PC";;;;
"PITPNB	IP_trans	[M-H]-: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	7800000	[M-H]-	36	2	neg	773.5322	7.94	7.42	8.2	PG	PG";;;;
"PITPNB	IP_trans	[M-H]-: Phosphatidylglycerol (33:1) => (17:1/16:0)	PG(33:1)	in vitro	890000	[M-H]-	33	1	neg	733.5012	7.38	6.83	7.63	PG	PG";;;;
"PITPNB	IP_trans	[M-H]-: Phosphatidylglycerol (37:2) => (19:1/18:1)	PG(37:2)	in vitro	240000	[M-H]-	37	2	neg	787.5476	8.79	8.36	9.05	PG	PG";;;;
"PITPNB	IP_trans	[M-H]-: Bismonoacylglycerolphosphate (33:2)";"Phosphatidylglycerol (33:2) => (17:1/16:1)	PG/BMP(33:2)	in vitro	120000	[M-H]-	33	2	neg	731.4856	6.35	5.72	6.59	PG";" BMP	PG/BMP";;
"PITPNB	IP_trans	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	100000	[M-H+1x(HCOONa)]-	36	2	neg	841.5189	7.94	7.41	8.25	PG	PG";;;;
"PITPNB	IP_trans	[M-H]-: Phosphatidylglycerol (36:1) => (18:1/18:0)	PG(36:1)	in vitro	50000	[M-H]-	36	1	neg	775.5478	9.17	8.86	9.44	PG	PG";;;;
"PITPNB	IP_trans	[M-H]-: Phosphatidylglycerol (30:0) => (14:0/16:0)	PG(30:0)	in vitro	35000	[M-H]-	30	0	neg	693.4699	6.42	5.98	6.61	PG	PG";;;;
"PITPNC1	IP_trans	[M+NH4]+: Phosphatidate (34:2) => (16:1/18:1)	PA(34:2)	in vitro	7100000	[M+NH4]+	34	2	pos	690.5062	7.37	6.19	8.11	PA	PA";;;;
"PITPNC1	IP_trans	[M+NH4]+: Phosphatidate (32:1) => (16:1/16:0)	PA(32:1)	in vitro	3800000	[M+NH4]+	32	1	pos	664.4911	7.13	6.01	7.79	PA	PA";;;;
"PITPNC1	IP_trans	[M+NH4]+: Phosphatidate (33:1) => (17:1/16:0)	PA(33:1)	in vitro	600000	[M+NH4]+	33	1	pos	678.5068	7.76	6.33	8.37	PA	PA";;;;
"PITPNC1	IP_trans	[M+Na]+: Phosphatidate (34:2)	PA(34:2)	in vitro	530000	[M+Na]+	34	2	pos	695.4611	7.2	6.15	7.66	PA	PA";;;;
"PITPNC1	IP_trans	[M+Na]+: Phosphatidate (32:1) => (16:1/16:0)	PA(32:1)	in vitro	350000	[M+Na]+	32	1	pos	669.4457	7.07	6.12	7.53	PA	PA";;;;
"PITPNC1	IP_trans	[M+H]+: Phosphatidate (34:2) => (16:1/18:1)	PA(34:2)	in vitro	170000	[M+H]+	34	2	pos	673.4799	7.19	6.39	7.57	PA	PA";;;;
"PITPNC1	IP_trans	[M+Na]+: Phosphatidate (35:2) => (18:1/17:1)	PA(35:2)	in vitro	110000	[M+Na]+	35	2	pos	709.4776	7.98	7.22	8.49	PA	PA";;;;
"PITPNC1	IP_trans	[M+Na]+: Phosphatidate (36:2) => (18:1/18:1)	PA(36:2)	in vitro	97000	[M+Na]+	36	2	pos	723.4932	8.44	7.7	8.99	PA	PA";;;;
"PITPNC1	IP_trans	[M+Na]+: Phosphatidate (34:1) => (16:0/18:1)	PA(34:1)	in vitro	76000	[M+Na]+	34	1	pos	697.4773	8.3	7.52	8.95	PA	PA";;;;
"PITPNC1	IP_trans	[M+Na]+: Phosphatidate (33:1)	PA(33:1)	in vitro	66000	[M+Na]+	33	1	pos	683.4615	7.85	7.11	8.29	PA	PA";;;;
"PITPNC1	IP_trans	[M+NH4]+: Phosphatidate (30:1) => (14:0/16:1)	PA(30:1)	in vitro	64000	[M+NH4]+	30	1	pos	636.46	5.86	4.91	6.37	PA	PA";;;;
"PITPNC1	IP_trans	[M+NH4]+: Phosphatidate (35:1) => (16:0/19:1)	PA(35:1)	in vitro	59000	[M+NH4]+	35	1	pos	706.5379	9.22	8.4	9.78	PA	PA";;;;
"PITPNC1	IP_trans	[M+Na]+: Phosphatidate (32:2) => (16:1/16:1)	PA(32:2)	in vitro	55000	[M+Na]+	32	2	pos	667.4308	6.04	5.05	6.39	PA	PA";;;;
"PITPNC1	IP_trans	[M-H]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	3400000	[M-H]-	34	2	neg	671.4648	7.19	6.35	7.73	PA	PA";;;;
"PITPNC1	IP_trans	[M-H]-: Phosphatidate (32:1)  => (16:0/16:1)	PA(32:1)	in vitro	2300000	[M-H]-	32	1	neg	645.4491	7.07	6.21	7.54	PA	PA";;;;
"PITPNC1	IP_trans	[M-H]-: Phosphatidate (35:2)  => (18:1/17:1)	PA(35:2)	in vitro	550000	[M-H]-	35	2	neg	685.4805	7.98	7.15	8.46	PA	PA";;;;
"PITPNC1	IP_trans	[M-H]-: Phosphatidate (36:2) => (18:1/18:1)	PA(36:2)	in vitro	430000	[M-H]-	36	2	neg	699.4964	8.45	7.7	9.02	PA	PA";;;;
"PITPNC1	IP_trans	[M-H]-: Phosphatidate (32:2) => (16:1/16:1)	PA(32:2)	in vitro	270000	[M-H]-	32	2	neg	643.434	6.04	5.21	6.42	PA	PA";;;;
"PITPNC1	IP_trans	[M-H+1x(HCOONa)]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	190000	[M-H+1x(HCOONa)]-	34	2	neg	739.4517	7.19	6.32	7.6	PA	PA";;;;
"PITPNC1	IP_trans	[M+HCOO]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	150000	[M+HCOO]-	34	2	neg	717.4695	7.2	6.41	7.53	PA	PA";;;;
"PITPNC1	IP_trans	[M-H+1x(HCOONa)]-: Phosphatidate (32:1)  => (16:0/16:1)	PA(32:1)	in vitro	120000	[M-H+1x(HCOONa)]-	32	1	neg	713.4361	7.07	6.22	7.44	PA	PA";;;;
"PITPNC1	IP_trans	[M+HCOO]-: Phosphatidate (32:1)  => (16:0/16:1)	PA(32:1)	in vitro	120000	[M+HCOO]-	32	1	neg	691.4542	7.07	6.4	7.39	PA	PA";;;;
"PITPNC1	IP_trans	[M-H+2x(HCOONa)]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	110000	[M-H+2x(HCOONa)]-	34	2	neg	807.4386	7.2	6.39	7.63	PA	PA";;;;
"PITPNC1	IP_trans	[M-H+2x(HCOONa)]-: Phosphatidate (32:1)  => (16:0/16:1)	PA(32:1)	in vitro	74000	[M-H+2x(HCOONa)]-	32	1	neg	781.4236	7.07	6.25	7.46	PA	PA";;;;
"PITPNC1	IP_trans	[M-H+3x(HCOONa)]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	52000	[M-H+3x(HCOONa)]-	34	2	neg	875.4264	7.2	6.4	7.61	PA	PA";;;;
"PITPNC1	IP_trans	[M-H+3x(HCOONa)]-: Phosphatidate (32:1)  => (16:0/16:1)	PA(32:1)	in vitro	34000	[M-H+3x(HCOONa)]-	32	1	neg	849.4106	7.08	6.29	7.46	PA	PA";;;;
"PITPNC1	IP_trans	[M-H+1x(HCOONa)]-: Phosphatidate (35:2)  => (18:1/17:1)	PA(35:2)	in vitro	32000	[M-H+1x(HCOONa)]-	35	2	neg	753.4665	7.98	7.33	8.4	PA	PA";;;;
"PITPNC1	IP_trans	[M-H]-: Phosphatidate (37:2) => (18:1/19:1)	PA(37:2)	in vitro	22000	[M-H]-	37	2	neg	713.5124	9.32	8.77	9.89	PA	PA";;;;
"PITPNC1	IP_trans	[M-H]-: Phosphatidylinositol (38:4)  => (18:0/20:4)	PI(38:4)	in vitro	21000	[M-H]-	38	4	neg	885.5479	7.85	7.19	8.06	PI	PI";;;;
"PITPNC1	IP_trans	[M-H+2x(HCOONa)]-: Phosphatidate (35:2)  => (18:1/17:1)	PA(35:2)	in vitro	21000	[M-H+2x(HCOONa)]-	35	2	neg	821.4547	7.98	7.34	8.4	PA	PA";;;;
"PMP2	lipocalin	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	1200000	[M-H]-	18	1	neg	281.2486	3.78	2.95	8.78	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	960000	[M-H]-	16	1	neg	253.2171	3.02	0.17	3.22	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: eicosatetraenoate => (20:4)	FA(20:4)	in vitro	280000	[M-H]-	20	4	neg	303.2331	3.17	2.16	3.34	FA	FA";;;;
"PMP2	lipocalin	[M+HCOO]-: octadecenoate  => (18:1)	FA(18:1)	in vitro	150000	[M+HCOO]-	18	1	neg	327.2541	3.72	1.57	8.75	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: heptadecenoate  => (17:1)	FA(17:1)	in vitro	130000	[M-H]-	17	1	neg	267.2329	3.5	2.62	3.67	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: docosapentaenoate => (22:5)	FA(22:5)	in vitro	67000	[M-H]-	22	5	neg	329.2489	3.3	2.38	3.63	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: octadecadienoate => (18:1)	FA(18:2)	in vitro	41000	[M-H]-	18	2	neg	279.233	3.25	2.28	3.51	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: nonadecenoate => (19:1)	FA(19:1)	in vitro	31000	[M-H]-	19	1	neg	295.2645	4.3	3.64	4.44	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: eicosatrienoate => (20:3)	FA(20:3)	in vitro	24000	[M-H]-	20	3	neg	305.2485	3.5	3.15	3.75	FA	FA";;;;
"PMP2	lipocalin	[M-H]-: eicosapentaenoate => (20:5)	FA(20:5)	in vitro	13000	[M-H]-	20	5	neg	301.2171	2.68	1.81	2.86	FA	FA";;;;
"RBP5	lipocalin	[M-H]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	13000	[M-H]-	16	1	neg	253.2169	3.06	2.26	3.21	FA	FA";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	32000000	[M+NH4]+	36	2	pos	792.5746	7.9	6.62	8.36	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (32:1) => (16:0/16:1)	PG(32:1)	in vitro	27000000	[M+NH4]+	32	1	pos	738.5277	6.61	5.27	6.9	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	23000000	[M+NH4]+	34	2	pos	764.5432	6.72	5.44	7.14	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	17000000	[M+H]+	34	2	pos	716.5218	7.79	7.26	8.27	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (34:1) => (16:0/18:1)	PE(34:1)	in vitro	12000000	[M+H]+	34	1	pos	718.5379	8.96	8.5	9.34	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	12000000	[M+NH4]+	33	1	pos	752.5433	7.35	6.21	7.65	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (33:1) => (16:0/17:1)	PE(33:1)	in vitro	11000000	[M+H]+	33	1	pos	704.5225	8.5	8	9	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	8900000	[M+H]+	36	2	pos	786.6002	8.86	8.38	9.7	PC	PC";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (35:2) => (18:1/17:1)	PE(35:2)	in vitro	7400000	[M+H]+	35	2	pos	730.5378	8.63	8.16	9	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	4100000	[M+H]+	32	2	pos	688.4908	6.55	5.92	7.05	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	3000000	[M+NH4]+	32	2	pos	736.5126	5.65	3.89	6.76	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (33:2) => (16:1/17:1)	PE(33:2)	in vitro	2900000	[M+H]+	33	2	pos	702.5063	7.33	6.78	7.65	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	2800000	[M+H]+	32	1	pos	721.5011	6.61	5.32	6.88	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	2600000	[M+H]+	34	1	pos	749.5321	7.78	6.62	8.05	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	2600000	[M+H]+	36	2	pos	775.548	7.9	6.88	8.35	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (30:1) => (14:0/16:1)	PE(30:1)	in vitro	2500000	[M+H]+	30	1	pos	662.4751	6.34	5.71	6.72	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	2200000	[M+NH4]+	33	2	pos	750.5276	6.32	5.01	7.77	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	1900000	[M+H]+	34	2	pos	747.5166	6.66	5.48	7.18	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (30:1) => (14:0/16:1)	PG(30:1)	in vitro	1900000	[M+NH4]+	30	1	pos	710.4958	5.52	4.04	6.01	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (30:0) => (14:0/16:0)	PE(30:0)	in vitro	1600000	[M+H]+	30	0	pos	664.4908	7.42	6.68	7.75	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	1500000	[M+H]+	33	1	pos	735.5164	7.35	6.24	7.61	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	1300000	[M+H]+	35	2	pos	761.5324	7.47	6.39	7.73	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (35:1) => (16:0/19:1)	PE(35:1)	in vitro	1200000	[M+H]+	35	1	pos	732.5541	9.88	9.49	10.25	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (30:0) => (14:0/16:0)	PG(30:0)	in vitro	1000000	[M+NH4]+	30	0	pos	712.512	6.4	5.14	6.68	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (37:2) => (18:1/19:1)	PE(37:2)	in vitro	790000	[M+H]+	37	2	pos	758.5703	9.99	9.49	10.34	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in vitro	720000	[M+H]+	34	1	pos	760.585	8.66	8.07	10.15	PC	PC";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (31:1) => (14:0/17:1)	PE(31:1)	in vitro	590000	[M+H]+	31	1	pos	676.491	7.1	6.52	7.46	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (32:0) => (16:0/16:0)	PE(32:0)	in vitro	390000	[M+H]+	32	0	pos	692.5223	8.81	8.1	9.3	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (31:1) => (14:0/17:1)	PG(31:1)	in vitro	350000	[M+NH4]+	31	1	pos	724.5103	6.11	4.8	7.11	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (35:1) => (16:0/19:1)	PG(35:1)	in vitro	320000	[M+H]+	35	1	pos	763.548	8.63	7.69	8.9	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (36:3) => (18:2/18:1)	PG(36:3)	in vitro	250000	[M+NH4]+	36	3	pos	790.5587	7.5	6.87	8.23	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	240000	[M+H]+	32	2	pos	719.4858	5.65	4.29	5.97	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (30:1) => (14:0/16:1)	PG(30:1)	in vitro	220000	[M+Na]+	30	1	pos	715.4522	5.48	3.92	5.8	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (28:0) => (14:0/14:0)	PE(28:0)	in vitro	200000	[M+H]+	28	0	pos	636.4596	6.13	5.16	6.39	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (28:0) => (14:0/14:0)	PG(28:0)	in vitro	180000	[M+NH4]+	28	0	pos	684.4818	5.3	3.8	6.57	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (30:1) => (14:0/16:1)	PG(30:1)	in vitro	170000	[M+H]+	30	1	pos	693.4702	5.48	4.08	5.8	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	170000	[M+H]+	33	2	pos	733.5005	6.32	5.14	6.52	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerophosphate (32:1) => (16:1/16:0)	PGP(32:1)	in vitro	120000	[M+NH4]+	32	1	pos	818.4946	5.59	5.06	8.16	PGP	PGP";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (30:0) => (14:0/16:0)	PG(30:0)	in vitro	120000	[M+H]+	30	0	pos	695.485	6.4	5.1	6.56	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (28:1) => (12:0/16:1)	PE(28:1)	in vitro	100000	[M+H]+	28	1	pos	634.4447	5.21	4.41	5.99	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+Na]+: Phosphatidylethanolamine (35:1) => (16:0/19:1)	PE(35:1)	in vitro	99000	[M+Na]+	35	1	pos	754.5368	9.87	9.51	10.21	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerophosphate (34:2) => (16:1/18:1)	PGP(34:2)	in vitro	92000	[M+NH4]+	34	2	pos	844.5099	5.66	5.24	6.87	PGP	PGP";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (68:3) => (16:0/16:1//18:1/18:1)	CL(68:3)	in vitro	83000	[M+NH4]+	68	3	pos	1421.0202	16.45	16.11	16.68	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (28:1) => (12:0/16:1)	PG(28:1)	in vitro	83000	[M+NH4]+	28	1	pos	682.4651	4.58	3.23	4.95	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (30:2) => (16:1/14:1)	PE(30:2)	in vitro	82000	[M+H]+	30	2	pos	660.4599	5.49	4.84	5.98	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylglycerophosphate (32:1) => (16:1/16:0)	PGP(32:1)	in vitro	70000	[M+H]+	32	1	pos	801.4679	5.59	5.24	6.47	PGP	PGP";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylcholine (38:3)	PC(38:3)	in vitro	61000	[M+H]+	38	3	pos	812.6154	9.52	8.31	10.25	PC	PC";;;;
"RLBP1	CRAL-TRIO	[M+Na]+: Phosphatidylethanolamine (37:2)	PE(37:2)	in vitro	60000	[M+Na]+	37	2	pos	780.5529	10.09	9.67	10.71	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (66:2) => (16:0/16:1//16:0/18:1)	CL(66:2)	in vitro	52000	[M+NH4]+	66	2	pos	1395.0067	16.43	16.11	16.63	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (30:2) => (16:1/14:1)	PG(30:2)	in vitro	51000	[M+NH4]+	30	2	pos	708.4816	4.8	3.23	5.33	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (70:3) => (18:1/16:0//18:1/18:1)	CL(70:3)	in vitro	43000	[M+NH4]+	70	3	pos	1449.0515	16.7	16.4	16.92	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (66:3) => (16:1/16:0//16:1/18:1)	CL(66:3)	in vitro	34000	[M+NH4]+	66	3	pos	1392.9905	16.15	16.05	16.61	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (38:2) => (20:1/18:1)	PE(38:2)	in vitro	32000	[M+H]+	38	2	pos	772.5865	10.5	10.08	11.15	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (69:3) => (33:1/36:2)	CL(69:3)	in vitro	30000	[M+NH4]+	69	3	pos	1435.0374	16.63	16.31	16.85	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (64:2) => (16:1/16:0//16:1/16:0)	CL(64:2)	in vitro	26000	[M+NH4]+	64	2	pos	1366.9766	16.13	15.74	16.37	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (70:4) => (18:1/16:1//18:1/18:1)	CL(70:4)	in vitro	25000	[M+NH4]+	70	4	pos	1447.0346	16.46	16.37	16.7	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (67:3) => (32:1/35:2)	CL(67:3)	in vitro	22000	[M+NH4]+	67	3	pos	1407.0063	16.36	16.06	16.77	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (67:2) =>  (16:0/17:1//16:0/18:1)	CL(67:2)	in vitro	16000	[M+NH4]+	67	2	pos	1409.0213	16.63	16.33	16.83	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M+NH4]+: Cardiolipin (68:4) => (16:1/18:1//16:1/18:1)	CL(68:4)	in vitro	12000	[M+NH4]+	68	4	pos	1419.0047	16.17	16.06	16.7	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	24000000	[M-H]-	32	1	neg	719.4877	6.61	5.19	6.89	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	20000000	[M-H]-	36	2	neg	773.5346	7.9	6.78	8.39	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	18000000	[M-H]-	34	2	neg	745.5034	6.72	5.33	7.13	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	18000000	[M-H]-	34	1	neg	747.5191	7.78	6.54	8.14	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (33:1) => (17:1/16:0)	PG(33:1)	in vitro	9600000	[M-H]-	33	1	neg	733.5034	7.35	6.14	7.63	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (35:2) => (17:1/18:1)	PG(35:2)	in vitro	9300000	[M-H]-	35	2	neg	759.5189	7.47	6.26	7.75	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (33:1) => (17:1/16:0)	PE(33:1)	in vitro	5900000	[M-H]-	33	1	neg	702.509	8.5	8.03	8.82	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in vitro	5700000	[M-H]-	34	1	neg	716.5245	8.96	7.72	9.33	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	4400000	[M-H]-	36	2	neg	742.5405	9.1	8.67	9.61	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (35:2) => (17:1/18:1)	PE(35:2)	in vitro	3500000	[M-H]-	35	2	neg	728.5246	8.63	8.16	8.97	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	2700000	[M-H]-	32	2	neg	717.4726	5.65	4.24	5.91	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (35:1) => (19:1/16:0)	PG(35:1)	in vitro	2100000	[M-H]-	35	1	neg	761.5344	8.64	7.86	8.95	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (37:2)";"Phosphatidylglycerol (37:2) => (19:1/18:1)	PG/BMP(37:2)	in vitro	2100000	[M-H]-	37	2	neg	787.5507	8.76	7.9	9.06	BMP";" PG	PG/BMP";;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (32:2)  => (16:1/16:1)	PE(32:2)	in vitro	1900000	[M-H]-	32	2	neg	686.4772	6.54	5.93	6.9	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	1900000	[M-H]-	33	2	neg	731.4868	6.32	4.98	6.57	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (33:2) =(17:1/16:1)	PE(33:2)	in vitro	1300000	[M-H]-	33	2	neg	700.4924	7.33	6.78	7.66	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (30:1) => (16:1/14:0)	PE(30:1)	in vitro	1300000	[M-H]-	30	1	neg	660.4619	6.34	5.72	6.69	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (35:1) => (19:1/16:0)	PE(35:1)	in vitro	630000	[M-H]-	35	1	neg	730.5415	9.89	9.51	10.21	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M+HCOO]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in vitro	450000	[M+HCOO]-	36	2	neg	830.5923	8.88	8.46	9.26	PC	PC";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (32:1) => (16:0/16:1)	PA(32:1)	in vitro	410000	[M-H]-	32	1	neg	645.4504	7.08	5.84	7.53	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	380000	[M-H]-	34	2	neg	671.4657	7.19	6.01	7.8	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (37:2) => (19:1/18:1)	PE(37:2)	in vitro	360000	[M-H]-	37	2	neg	756.5567	10.01	9.65	10.32	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	320000	[M-H]-	18	1	neg	281.2488	3.79	3.03	8.78	FA	FA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (31:1) => (17:1/14:0)	PG(31:1)	in vitro	310000	[M-H]-	31	1	neg	705.4715	6.12	4.79	6.33	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (31:1) => (17:1/14:0)	PE(31:1)	in vitro	270000	[M-H]-	31	1	neg	674.4766	7.1	6.56	7.39	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (28:0) => (14:0/14:0)	PG(28:0)	in vitro	180000	[M-H]-	28	0	neg	665.4412	5.31	3.98	5.53	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerophosphate (34:2) => (18:1/16:1)	PGP(34:2)	in vitro	170000	[M-H]-	34	2	neg	825.4694	5.66	5.22	8.37	PGP	PGP";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (36:2) => (18:1/18:1)	PA(36:2)	in vitro	170000	[M-H]-	36	2	neg	699.4979	8.45	7.47	8.99	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (34:1) => (16:0/18:1)	PA(34:1)	in vitro	160000	[M-H]-	34	1	neg	673.4818	8.31	7.36	8.8	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (32:0) => (16:0/16:0)	PE(32:0)	in vitro	130000	[M-H]-	32	0	neg	690.5085	8.81	8.36	9.17	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (36:3) => (18:1/18:2)	PG(36:3)	in vitro	130000	[M-H]-	36	3	neg	771.5165	7.5	6.81	7.83	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	120000	[M-H+1x(HCOONa)]-	32	2	neg	785.4588	5.65	4.03	5.89	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerophosphate (36:2) => (18:1/18:1)	PGP(36:2)	in vitro	110000	[M-H]-	36	2	neg	853.4994	6.7	5.63	9.41	PGP	PGP";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (32:2) => (16:1/16:1)	PA(32:2)	in vitro	110000	[M-H]-	32	2	neg	643.4341	6.03	4.93	6.41	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (35:2) => (18:1/17:1)	PA(35:2)	in vitro	110000	[M-H]-	35	2	neg	685.4811	7.97	6.93	8.48	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (28:0) => (14:0/14:0)	PE(28:0)	in vitro	92000	[M-H]-	28	0	neg	634.4453	6.13	5.53	6.38	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (34:3)";"Bismonoacylglycerolphosphate (34:3) => (16:1/18:2)	PG/BMP(34:3)	in vitro	89000	[M-H]-	34	3	neg	743.4862	6.44	4.84	6.82	BMP";" PG	PG/BMP";;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (28:1) => (16:1/12:0)	PG(28:1)	in vitro	83000	[M-H]-	28	1	neg	663.4253	4.56	3.22	4.89	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (36:1)	PE(36:1)	in vitro	75000	[M-H]-	36	1	neg	744.5573	10.41	10.04	10.72	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (28:1) => (16:1/12:0)	PE(28:1)	in vitro	66000	[M-H]-	28	1	neg	632.4307	5.2	4.55	5.64	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H+2x(HCOONa)]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	63000	[M-H+2x(HCOONa)]-	32	2	neg	853.446	5.65	3.89	5.91	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (30:2) => (14:1/16:1)	PE(30:2)	in vitro	53000	[M-H]-	30	2	neg	658.4456	5.48	4.82	6.05	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (30:1) => (14:0/16:1)	PA(30:1)	in vitro	52000	[M-H]-	30	1	neg	617.4187	5.84	4.69	6.22	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (30:2) => (16:1/14:1)	PG(30:2)	in vitro	50000	[M-H]-	30	2	neg	689.4413	4.78	3.4	5.26	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidate (33:2) => (16:1/17:1)	PA(33:2)	in vitro	47000	[M-H]-	33	2	neg	657.449	6.75	5.51	7.11	PA	PA";;;;
"RLBP1	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (35:1) => (19:1/16:0)	PE(35:1)	in vitro	46000	[M-H+1x(HCOONa)]-	35	1	neg	798.5285	9.88	9.51	10.17	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H+3x(HCOONa)]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	31000	[M-H+3x(HCOONa)]-	32	2	neg	921.4335	5.5	3.88	5.89	PG	PG";;;;
"RLBP1	CRAL-TRIO	[M-H+2x(HCOONa)]-: Phosphatidylethanolamine (35:1) => (19:1/16:0)	PE(35:1)	in vitro	29000	[M-H+2x(HCOONa)]-	35	1	neg	866.516	9.88	9.52	10.18	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (38:2)";"Bismonoacylglycerolphosphate (38:2) => (19:1/19:1)	PG/BMP(38:2)	in vitro	27000	[M-H]-	38	2	neg	801.5669	9.63	9.45	9.89	BMP";" PG	PG/BMP";;
"RLBP1	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (37:2) => (19:1/18:1)	PE(37:2)	in vitro	26000	[M-H+1x(HCOONa)]-	37	2	neg	824.5445	10.01	9.65	10.3	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Cardiolipin (68:3)	CL(68:3)	in vitro	22000	[M-H]-	68	3	neg	1401.9828	16.44	16.34	16.63	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (37:1)";"Phosphatidylglycerol (37:1) => (19:1/18:0)	PG/BMP(37:1)	in vitro	22000	[M-H]-	37	1	neg	789.567	9.98	9.29	10.25	PG";" BMP	PG/BMP";;
"RLBP1	CRAL-TRIO	[M-H+3x(HCOONa)]-: Phosphatidylethanolamine (35:1) => (19:1/16:0)	PE(35:1)	in vitro	17000	[M-H+3x(HCOONa)]-	35	1	neg	934.5043	9.88	9.52	10.18	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Cardiolipin (66:2)	CL(66:2)	in vitro	16000	[M-H]-	66	2	neg	1375.9669	16.42	16.31	16.61	CL	CL";;;;
"RLBP1	CRAL-TRIO	[M-H+2x(HCOONa)]-: Phosphatidylethanolamine (37:2) => (19:1/18:1)	PE(37:2)	in vitro	16000	[M-H+2x(HCOONa)]-	37	2	neg	892.5318	10.01	9.65	10.3	PE	PE";;;;
"RLBP1	CRAL-TRIO	[M-H]-: Cardiolipin (66:3)	CL(66:3)	in vitro	14000	[M-H]-	66	3	neg	1373.9516	16.15	16.02	16.34	CL	CL";;;;
"SCP2	scp2	[M+NH4]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	260000	[M+NH4]+	32	1	pos	738.528	6.62	5.64	6.9	PG	PG";;;;
"SCP2	scp2	[M+H]+: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	150000	[M+H]+	32	2	pos	688.4911	6.54	6.09	6.9	PE	PE";;;;
"SCP2	scp2	[M+H]+: Lysophosphatidylglycerol (18:1) => (18:1)	LPG(18:1)	in vitro	60000	[M+H]+	18	1	pos	511.3032	1.98	0.9	2.15	Lyso-PG	LPG";;;;
"SCP2	scp2	[M+NH4]+: Phosphatidylglycerol (30:1) => (14:0/16:1)	PG(30:1)	in vitro	60000	[M+NH4]+	30	1	pos	710.4935	5.57	4.5	6.09	PG	PG";;;;
"SCP2	scp2	[M+NH4]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	24000	[M+NH4]+	32	2	pos	736.5122	5.65	4.88	6.27	PG	PG";;;;
"SCP2	scp2	[M-H]-: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	190000	[M-H]-	32	1	neg	719.4862	6.63	5.56	6.91	PG	PG";;;;
"SCP2	scp2	[M-H]-: Phosphatidylglycerol (34:2)";"Bismonoacylglycerolphosphate (34:2) => (16:1/18:1)	PG/BMP(34:2)	in vitro	130000	[M-H]-	34	2	neg	745.5023	6.74	5.71	7.19	PG";" BMP	PG/BMP";;
"SCP2	scp2	[M-H]-: Phosphatidylethanolamine (32:2) = (16:1/16:1)	PE(32:2)	in vitro	61000	[M-H]-	32	2	neg	686.4763	6.55	5.95	6.94	PE	PE";;;;
"SCP2	scp2	[M-H]-: Lysophosphatidylglycerol (18:1) => (18:1)	LPG(18:1)	in vitro	55000	[M-H]-	18	1	neg	509.2872	1.91	1.11	2.15	Lyso-PG	LPG";;;;
"SCP2	scp2	[M-H]-: Bismonoacylglycerolphosphate (33:1)";"Phosphatidylglycerol (33:1) => (17:1/16:0)	PG/BMP(33:1)	in vitro	54000	[M-H]-	33	1	neg	733.5015	7.36	6.46	7.65	BMP";" PG	PG/BMP";;
"SCP2	scp2	[M-H]-: Bismonoacylglycerolphosphate (30:1)";"Phosphatidylglycerol (30:1) => (16:1/14:0)	PG/BMP(30:1)	in vitro	37000	[M-H]-	30	1	neg	691.4552	5.5	4.23	5.79	BMP";" PG	PG/BMP";;
"SCP2	scp2	[M-H]-: Phosphatidylethanolamine (33:2) => (17:1/16:1)	PE(33:2)	in vitro	31000	[M-H]-	33	2	neg	700.4911	7.34	6.79	7.68	PE	PE";;;;
"SCP2	scp2	[M-H]-: Lysophosphatidylglycerol (18:1) => (18:1)	LPG(18:1)	in vitro	21000	[M-H]-	18	1	neg	509.2874	2.02	1.94	2.11	Lyso-PG	LPG";;;;
"SCP2	scp2	[M-H]-: Lysophosphatidylglycerol (17:1) => (17:1)	LPG(17:1)	in vitro	21000	[M-H]-	17	1	neg	495.272	1.65	0.83	1.82	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylethanolamine (18:1) => (18:1)	LPE(18:1)	in vitro	720000	[M+H]+	18	1	pos	480.3086	2.34	0.16	2.55	Lyso-PE	LPE";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	550000	[M+H]+	17	1	pos	466.2928	2.01	0.15	2.2	Lyso-PE	LPE";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylethanolamine (19:1) => (19:1)	LPE(19:1)	in vitro	300000	[M+H]+	19	1	pos	494.324	2.88	1.79	3.05	Lyso-PE	LPE";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylcholine (18:1) => (18:1)	LPC(18:1)	in vitro	190000	[M+H]+	18	1	pos	522.3558	2.28	1.18	2.5	Lyso-PC	LPC";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylcholine (18:0) => (18:0)	LPC(18:0)	in vitro	150000	[M+H]+	18	0	pos	524.3712	2.97	2.14	3.17	Lyso-PC	LPC";;;;
"SCP2D1	scp2	[M+NH4]+: Lysophosphatidylglycerol (19:1) => (19:1)	LPG(19:1)	in vitro	130000	[M+NH4]+	19	1	pos	542.3455	2.44	0.14	2.76	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylcholine (18:2)	LPC(18:2)	in vitro	94000	[M+H]+	18	2	pos	520.34	1.68	0.47	2.33	Lyso-PC	LPC";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylglycerol (18:1) => (18:1)	LPG(18:1)	in vitro	77000	[M+H]+	18	1	pos	511.3033	2.04	0.69	2.24	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylethanolamine (16:1)";"Phosphatidylethanolamine (O-16:1)	PE(O-16:1)/LPE(16:1)	in vitro	54000	[M+H]+	16	1	pos	452.2768	1.47	0.14	1.7	Lyso-PE";" PE-O	LPE";;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylcholine (20:4)	LPC(20:4)	in vitro	41000	[M+H]+	20	4	pos	544.3397	1.64	0.58	1.99	Lyso-PC	LPC";;;;
"SCP2D1	scp2	[M+NH4]+: Lysophosphatidylglycerol (18:1)	LPG(18:1)	in vitro	37000	[M+NH4]+	18	1	pos	528.3295	1.91	0.26	2.16	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylglycerol (17:1) => (17:1)	LPG(17:1)	in vitro	34000	[M+H]+	17	1	pos	497.2872	1.73	0.51	1.87	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylcholine (22:5)	LPC(22:5)	in vitro	32000	[M+H]+	22	5	pos	570.357	1.72	0.6	2.06	Lyso-PC	LPC";;;;
"SCP2D1	scp2	[M+H]+: Lysophosphatidylcholine (20:3)";"Phosphatidylcholine (O-20:3)	PC(O-20:3)/LPC(20:3)	in vitro	25000	[M+H]+	20	3	pos	546.3556	2	1.58	2.11	Lyso-PC";" PC-O	LPC";;
"SCP2D1	scp2	[M+Na]+: Lysophosphatidylethanolamine (18:1)";"Phosphatidylethanolamine (O-18:1)	PE(O-18:1)/LPE(18:1)	in vitro	20000	[M+Na]+	18	1	pos	502.2903	2.35	1.14	2.46	Lyso-PE";" PE-O	LPE";;
"SCP2D1	scp2	[M-H]-: Lysophosphatidylethanolamine (18:1) => (18:1)	LPE(18:1)	in vitro	400000	[M-H]-	18	1	neg	478.2939	2.33	1.53	2.45	Lyso-PE	LPE";;;;
"SCP2D1	scp2	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	380000	[M-H]-	18	1	neg	281.2482	3.82	3.28	4.54	FA	FA";;;;
"SCP2D1	scp2	[M-H]-: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	340000	[M-H]-	17	1	neg	464.2778	2.01	0.15	2.13	Lyso-PE	LPE";;;;
"SCP2D1	scp2	[M-H]-: Lysophosphatidylglycerol (19:1) => (19:1)	LPG(19:1)	in vitro	320000	[M-H]-	19	1	neg	523.3039	2.42	1.95	2.64	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M-H]-:  Lysophosphatidylethanolamine (19:1) => (19:1)	LPE(19:1)	in vitro	150000	[M-H]-	19	1	neg	492.3095	2.88	2.1	2.98	Lyso-PE	LPE";;;;
"SCP2D1	scp2	[M-H]-: Lysophosphatidylglycerol (18:1)	LPG(18:1)	in vitro	140000	[M-H]-	18	1	neg	509.2881	1.96	0.11	2.15	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M-H]-: Bismonoacylglycerolphosphate (36:2)";"Phosphatidylglycerol (36:2) => (18:1/18:1)	PG/BMP(36:2)	in vitro	140000	[M-H]-	36	2	neg	773.5346	7.98	7.38	8.44	BMP";" PG	PG/BMP";;
"SCP2D1	scp2	[M-H]-: Phosphatidylglycerol (34:2)";"Bismonoacylglycerolphosphate (34:2) => (16:1/18:1)	PG/BMP(34:2)	in vitro	100000	[M-H]-	34	2	neg	745.5037	6.8	6.06	7.21	PG";" BMP	PG/BMP";;
"SCP2D1	scp2	[M-H]-: Phosphatidylethanolamine (33:1) =>(17:1/16:0)	PE(33:1)	in vitro	93000	[M-H]-	33	1	neg	702.5088	8.64	8.31	8.93	PE	PE";;;;
"SCP2D1	scp2	[M-H]-: Phosphatidylglycerol (34:1)";"Bismonoacylglycerolphosphate (34:1) => (18:1/16:0)	PG/BMP(34:1)	in vitro	76000	[M-H]-	34	1	neg	747.519	7.86	7.37	8.13	PG";" BMP	PG/BMP";;
"SCP2D1	scp2	[M-H]-: Bismonoacylglycerolphosphate (33:1)";"Phosphatidylglycerol (33:1) => (17:1/16:0)	PG/BMP(33:1)	in vitro	75000	[M-H]-	33	1	neg	733.5029	7.43	6.76	7.67	BMP";" PG	PG/BMP";;
"SCP2D1	scp2	[M-H]-: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	70000	[M-H]-	34	2	neg	714.5087	7.93	7.57	8.44	PE	PE";;;;
"SCP2D1	scp2	[M-H]-: Phosphatidylethanolamine (35:2) => (17:1/18:1)	PE(35:2)	in vitro	65000	[M-H]-	35	2	neg	728.5246	8.78	8.45	9.07	PE	PE";;;;
"SCP2D1	scp2	[M-H]-: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	56000	[M-H]-	36	2	neg	742.5401	9.25	8.95	9.81	PE	PE";;;;
"SCP2D1	scp2	[M-H]-: Lysophosphatidylglycerol (17:1) => (17:1)	LPG(17:1)	in vitro	51000	[M-H]-	17	1	neg	495.2727	1.68	0.11	1.82	Lyso-PG	LPG";;;;
"SCP2D1	scp2	[M-H]-: Phosphatidylethanolamine (32:1) => (16:1/16:0)	PE(32:1)	in vitro	46000	[M-H]-	32	1	neg	688.493	7.8	7.39	8.11	PE	PE";;;;
"SCP2D1	scp2	[M-H]-: Phosphatidylglycerol (32:1)";"Bismonoacylglycerolphosphate (32:1) => (16:1/16:0)	PG/BMP(32:1)	in vitro	44000	[M-H]-	32	1	neg	719.4874	6.68	5.9	6.92	PG";" BMP	PG/BMP";;
"SCP2D1	scp2	[M-H]-: Phosphatidylglycerol (35:1)";"Bismonoacylglycerolphosphate (35:1) => (19:1/16:0)	PG/BMP(35:1)	in vitro	25000	[M-H]-	35	1	neg	761.5344	8.71	8.19	8.96	PG";" BMP	PG/BMP";;
"SCP2D1	scp2	[M-H]-: eicosatetraenoate => (20:4)	FA(20:4)	in vitro	15000	[M-H]-	20	4	neg	303.233	3.2	2.6	3.33	FA	FA";;;;
"SCP2D1	scp2	[M+HCOO]-: Lysophosphatidylcholine (18:1) => (18:1)	LPC(18:1)	in vitro	15000	[M+HCOO]-	18	1	neg	566.3464	2.28	1.53	2.45	Lyso-PC	LPC";;;;
"SCP2D1	scp2	[M-H]-: Lysophosphatidylethanolamine (18:0) => (18:0)	LPE(18:0)	in vitro	14000	[M-H]-	18	0	neg	480.3094	3.07	2.48	3.18	Lyso-PE	LPE";;;;
"SCP2D1	scp2	[M+HCOO]-: Lysophosphatidylcholine (18:0) => (18:0)	LPC(18:0)	in vitro	12000	[M+HCOO]-	18	0	neg	568.3616	2.97	2.28	3.1	Lyso-PC	LPC";;;;
"SEC14L4	CRAL-TRIO	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	150000	[M-H]-	18	1	neg	281.2485	3.82	3.49	4.6	FA	FA";;;;
"SEC14L4	CRAL-TRIO	[M-H]-: heptadecenoate => (17:1)	FA(17:1)	in vitro	64000	[M-H]-	17	1	neg	267.2329	3.54	3.27	3.68	FA	FA";;;;
"SEC14L4	CRAL-TRIO	[M-H]-: hexadecenoate => (16:1)	FA(16:1)	in vitro	34000	[M-H]-	16	1	neg	253.2171	3.05	2.68	3.21	FA	FA";;;;
"SEC14L5	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (31:1) => (17:1/14:0)	PE(31:1)	in vitro	90000	[M-H]-	31	1	neg	674.4755	7.1	6.62	7.38	PE	PE";;;;
"SEC14L5	CRAL-TRIO	[M-H]-: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	32000	[M-H]-	17	1	neg	464.2784	1.95	0.87	2.83	Lyso-PE	LPE";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	350000000	[M+H]+	36	2	pos	786.5993	8.97	7.91	10.55	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (34:1)	PC(34:1)	in vitro	6300000	[M+H]+	34	1	pos	760.5848	8.76	8.48	9.33	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:4)	PC(38:4)	in vitro	5800000	[M+H]+	38	4	pos	810.5977	9.1	8.87	9.44	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:5)	PC(38:5)	in vitro	4200000	[M+H]+	38	5	pos	808.5837	7.8	7.23	9.51	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:5)	PC(40:5)	in vitro	3600000	[M+H]+	40	5	pos	836.6143	9.21	8.9	9.58	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (34:2)	PC(34:2)	in vitro	3300000	[M+H]+	34	2	pos	758.5693	7.74	7.16	9.38	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:1)	PC(36:1)	in vitro	3100000	[M+H]+	36	1	pos	788.617	10.22	9.96	10.81	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in vitro	2800000	[M+H]+	36	3	pos	784.5846	8.09	7.49	8.83	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:4)	PC(36:4)	in vitro	2600000	[M+H]+	36	4	pos	782.5688	7.66	7.29	7.99	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:4)	PC(38:4)	in vitro	2500000	[M+H]+	38	4	pos	810.6	8.67	8.06	9.63	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:3)	PC(38:3)	in vitro	2400000	[M+H]+	38	3	pos	812.6145	9.63	9.13	10.15	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:4)	PC(40:4)	in vitro	1800000	[M+H]+	40	4	pos	838.633	10.13	9.07	10.54	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:6)	PC(40:6)	in vitro	1200000	[M+H]+	40	6	pos	834.5992	8.83	8.56	9.13	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:6)	PC(38:6)	in vitro	1100000	[M+H]+	38	6	pos	806.5693	7.4	7.07	7.73	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:6)	PC(40:6)	in vitro	920000	[M+H]+	40	6	pos	834.5998	8.17	7.15	9.79	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (32:1)	PC(32:1)	in vitro	770000	[M+H]+	32	1	pos	732.5534	7.39	7.15	8.37	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:4)	PC(36:4)	in vitro	610000	[M+H]+	36	4	pos	782.5695	6.95	6.55	8.56	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:7)	PC(40:7)	in vitro	490000	[M+H]+	40	7	pos	832.5846	7.55	6.62	8.02	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:5)	PC(40:5)	in vitro	450000	[M+H]+	40	5	pos	836.616	9.68	9.51	10.05	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (34:3)	PC(34:3)	in vitro	410000	[M+H]+	34	3	pos	756.554	6.86	6.39	7.52	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (35:2)	PC(35:2)	in vitro	390000	[M+H]+	35	2	pos	772.5878	8.51	7.57	10.34	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:6)	PC(38:6)	in vitro	370000	[M+H]+	38	6	pos	806.57	6.84	6.47	7.32	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (36:5)	PC(36:5)	in vitro	330000	[M+H]+	36	5	pos	780.5541	6.79	6.07	7.19	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (35:1)	PC(35:1)	in vitro	290000	[M+H]+	35	1	pos	774.5998	9.49	9.05	9.87	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (37:4)	PC(37:4)	in vitro	250000	[M+H]+	37	4	pos	796.585	8.36	7.57	8.77	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-36:5)";"Lysophosphatidylcholine (36:5)	PC(O-36:5)/LPC(36:5)	in vitro	240000	[M+H]+	36	5	pos	766.5742	8.27	7.85	8.66	PC-O";" Lyso-PC	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-34:1)	PC(O-34:1)	in vitro	240000	[M+H]+	34	1	pos	746.604	9.62	9.33	9.96	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Lysophosphatidylcholine (38:5)";"Phosphatidylcholine (O-38:5)	PC(O-38:5)/LPC(38:5)	in vitro	220000	[M+H]+	38	5	pos	794.605	9.31	9.01	9.92	PC-O";" Lyso-PC	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:2)	PC(38:2)	in vitro	200000	[M+H]+	38	2	pos	814.6329	10.45	9.31	11.67	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (39:5)	PC(39:5)	in vitro	180000	[M+H]+	39	5	pos	822.6007	8.48	7.97	8.87	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (39:4)	PC(39:4)	in vitro	180000	[M+H]+	39	4	pos	824.6156	9.37	8.98	9.91	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (33:1)	PC(33:1)	in vitro	160000	[M+H]+	33	1	pos	746.5692	8.05	7.73	8.95	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-36:6)";"Lysophosphatidylcholine (36:6)	PC(O-36:6)/LPC(36:6)	in vitro	130000	[M+H]+	36	6	pos	764.5591	7.19	6.81	7.68	PC-O";" Lyso-PC	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-37:6)	PC(O-37:6)	in vitro	130000	[M+H]+	37	6	pos	778.5737	7.67	6.9	8.44	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-34:3)	PC(O-34:3)	in vitro	120000	[M+H]+	34	3	pos	742.5743	8.37	8.06	8.83	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-38:7)	PC(O-38:7)	in vitro	120000	[M+H]+	38	7	pos	790.5743	7.96	7.64	8.27	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-35:5)	PC(O-35:5)	in vitro	110000	[M+H]+	35	5	pos	752.559	7.26	7.07	7.85	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-36:3)	PC(O-36:3)	in vitro	110000	[M+H]+	36	3	pos	770.604	9.59	9.35	10.01	PC-O	PC-O";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (34:1)	PC(34:1)	in vitro	100000	[M+Na]+	34	1	pos	782.566	8.74	8.57	8.91	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-36:2)	PC(O-36:2)	in vitro	91000	[M+H]+	36	2	pos	772.622	9.78	9.47	10.27	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-34:4)";"Lysophosphatidylcholine (34:4)	PC(O-34:4)/LPC(34:4)	in vitro	90000	[M+H]+	34	4	pos	740.5587	7.32	6.75	7.81	PC-O";" Lyso-PC	PC-O";;
"STARD2	START	[M+Na]+: Phosphatidylcholine (38:5)	PC(38:5)	in vitro	87000	[M+Na]+	38	5	pos	830.5656	7.68	6.81	8.4	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (32:2)	PC(32:2)	in vitro	85000	[M+H]+	32	2	pos	730.5383	6.33	6.07	9.07	PC	PC";;;;
"STARD2	START	[M+H]+: Lysophosphatidylcholine (36:4)";"Phosphatidylcholine (O-36:4)	PC(O-36:4)/LPC(36:4)	in vitro	85000	[M+H]+	36	4	pos	768.5901	8.5	8.1	8.87	Lyso-PC";" PC-O	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:8)	PC(40:8)	in vitro	84000	[M+H]+	40	8	pos	830.5695	6.62	6.29	6.93	PC	PC";;;;
"STARD2	START	[M+H]+: Lysophosphatidylcholine (38:5)";"Phosphatidylcholine (O-38:5)	PC(O-38:5)/LPC(38:5)	in vitro	78000	[M+H]+	38	5	pos	794.6049	8.61	8.35	8.85	PC-O";" Lyso-PC	PC-O";;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-34:2)	PC(O-34:2)	in vitro	77000	[M+H]+	34	2	pos	744.5895	9.42	9.19	9.8	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-38:7)	PC(O-38:7)	in vitro	77000	[M+H]+	38	7	pos	790.5744	7.3	7.11	8.36	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:7)	PC(40:7)	in vitro	76000	[M+H]+	40	7	pos	832.5789	9.07	8.99	9.43	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (32:0)	PC(32:0)	in vitro	73000	[M+H]+	32	0	pos	734.569	8.52	8.27	8.77	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (42:8)	PC(42:8)	in vitro	66000	[M+H]+	42	8	pos	858.5996	7.64	7.16	8.03	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (37:5)	PC(37:5)	in vitro	66000	[M+H]+	37	5	pos	794.5695	7.13	6.86	7.97	PC	PC";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (40:5)	PC(40:5)	in vitro	65000	[M+Na]+	40	5	pos	858.5968	9.17	9.05	9.77	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-37:7)	PC(O-37:7)	in vitro	62000	[M+H]+	37	7	pos	776.558	7.01	6.77	7.53	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (38:7)	PC(38:7)	in vitro	60000	[M+H]+	38	7	pos	804.554	6.29	5.87	7.4	PC	PC";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (36:4)	PC(36:4)	in vitro	59000	[M+Na]+	36	4	pos	804.5502	7.64	7.45	7.93	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-32:1)	PC(O-32:1)	in vitro	57000	[M+H]+	32	1	pos	718.5742	8.34	7.93	8.77	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (39:6)	PC(39:6)	in vitro	57000	[M+H]+	39	6	pos	820.5841	8.06	7.19	8.4	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-33:3)	PC(O-33:3)	in vitro	54000	[M+H]+	33	3	pos	728.5578	7.59	7.2	8.18	PC-O	PC-O";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (36:1)	PC(36:1)	in vitro	53000	[M+Na]+	36	1	pos	810.5989	10.19	9.96	10.52	PC	PC";;;;
"STARD2	START	[M+H]+: Lysophosphatidylcholine (34:5)";"Phosphatidylcholine (O-34:5)	PC(O-34:5)/LPC(34:5)	in vitro	52000	[M+H]+	34	5	pos	738.543	6.84	6.6	7.16	Lyso-PC";" PC-O	PC-O";;
"STARD2	START	[M+Na]+: Phosphatidylcholine (40:4)	PC(40:4)	in vitro	36000	[M+Na]+	40	4	pos	860.6141	10.09	9.87	10.4	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-32:3)	PC(O-32:3)	in vitro	30000	[M+H]+	32	3	pos	714.5431	6.97	6.6	7.44	PC-O	PC-O";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (34:4)	PC(34:4)	in vitro	29000	[M+H]+	34	4	pos	754.5381	6.3	5.68	6.64	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (35:4)	PC(35:4)	in vitro	28000	[M+H]+	35	4	pos	768.5537	6.94	6.47	7.32	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (O-38:8)	PC(O-38:8)	in vitro	28000	[M+H]+	38	8	pos	788.5587	6.9	6.69	7.23	PC-O	PC-O";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (38:4)	PC(38:4)	in vitro	27000	[M+Na]+	38	4	pos	832.5811	8.64	8.15	8.81	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (40:6)	PC(40:6)	in vitro	26000	[M+H]+	40	6	pos	834.5976	9.65	9.43	9.84	PC	PC";;;;
"STARD2	START	[M+H]+: Phosphatidylcholine (42:10)	PC(42:10)	in vitro	22000	[M+H]+	42	10	pos	854.5691	6.38	6.2	7.23	PC	PC";;;;
"STARD2	START	[M+Na]+: Phosphatidylcholine (O-37:4)	PC(O-37:4)	in vitro	11000	[M+Na]+	37	4	pos	804.5899	8.46	8.22	8.73	PC-O	PC-O";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in vitro	27000000	[M+HCOO]-	36	2	neg	830.5914	9.04	8.81	9.53	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (34:1) =>(18:1/16:0)	PC(34:1)	in vitro	680000	[M+HCOO]-	34	1	neg	804.5759	8.83	8.58	9.25	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (38:5) =>(22:5/16:0)	PC(38:5)	in vitro	510000	[M+HCOO]-	38	5	neg	852.5754	7.85	7.56	8.56	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (38:4) =>(20:4/18:0)	PC(38:4)	in vitro	420000	[M+HCOO]-	38	4	neg	854.5894	9.18	8.92	9.6	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (34:2) =>(18:2/16:0)	PC(34:2)	in vitro	400000	[M+HCOO]-	34	2	neg	802.5601	7.81	7.47	8.35	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (36:4) =>(20:4/16:0)	PC(36:4)	in vitro	330000	[M+HCOO]-	36	4	neg	826.5603	7.73	7.47	8.12	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (36:1) =>(18:1/18:0)	PC(36:1)	in vitro	310000	[M+HCOO]-	36	1	neg	832.6084	10.31	10.08	10.77	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (36:3) =>(18:2/18:1)	PC(36:3)	in vitro	300000	[M+HCOO]-	36	3	neg	828.5766	8.16	7.51	8.84	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (40:5) =>(22:5/18:0)	PC(40:5)	in vitro	280000	[M+HCOO]-	40	5	neg	880.6059	9.29	9.03	9.66	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (38:3) => (20:3/18:0)	PC(38:3)	in vitro	220000	[M+HCOO]-	38	3	neg	856.6071	9.71	9.2	10.26	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (38:4) => (22:4/16:0)	PC(38:4)	in vitro	210000	[M+HCOO]-	38	4	neg	854.5917	8.79	8.2	9.53	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (38:6) => (16:0/22:6)	PC(38:6)	in vitro	150000	[M+HCOO]-	38	6	neg	850.5605	7.46	7.21	7.79	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (40:6) => (18:0/22:6)	PC(40:6)	in vitro	98000	[M+HCOO]-	40	6	neg	878.5916	8.79	7.22	9.38	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (32:1) => (16:1/16:0)	PC(32:1)	in vitro	94000	[M+HCOO]-	32	1	neg	776.5445	7.47	7.19	8.23	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (40:6) => (22:5/18:1)	PC(40:6)	in vitro	88000	[M+HCOO]-	40	6	neg	878.59	8.51	7.45	9.4	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (36:4) => (18:2/18:2)	PC(36:4)	in vitro	84000	[M+HCOO]-	36	4	neg	826.5611	7.11	6.56	8.34	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (40:7) => (18:1/22:6)	PC(40:7)	in vitro	56000	[M+HCOO]-	40	7	neg	876.5751	7.62	6.86	8.08	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (38:6) => (20:4/18:2)	PC(38:6)	in vitro	51000	[M+HCOO]-	38	6	neg	850.5596	7	6.51	7.71	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (40:5) => (22:5/18:0)	PC(40:5)	in vitro	49000	[M+HCOO]-	40	5	neg	880.6078	9.71	8.97	10.14	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (36:5) => (20:4/16:1)	PC(36:5)	in vitro	44000	[M+HCOO]-	36	5	neg	824.5435	6.89	6.15	7.29	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (35:2) => (18:2/17:0)	PC(35:2)	in vitro	39000	[M+HCOO]-	35	2	neg	816.5747	8.52	8.08	8.89	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (35:1) => (18:1/17:0)	PC(35:1)	in vitro	30000	[M+HCOO]-	35	1	neg	818.5915	9.58	9.16	10.09	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (37:4) => (20:4/17:0)	PC(37:4)	in vitro	29000	[M+HCOO]-	37	4	neg	840.5759	8.43	7.7	8.79	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (39:5) => (22:5/17:0)	PC(39:5)	in vitro	19000	[M+HCOO]-	39	5	neg	866.5917	8.55	8.11	8.89	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (39:4) => (22:4/17:0)	PC(39:4)	in vitro	18000	[M+HCOO]-	39	4	neg	868.6065	9.13	7.8	10.05	PC	PC";;;;
"STARD2	START	[M+HCOO]-: Phosphatidylcholine (33:1) => (17:1/16:0)	PC(33:1)	in vitro	17000	[M+HCOO]-	33	1	neg	790.5607	8.12	7.9	8.52	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	64000000	[M+H]+	36	2	pos	744.5533	9.15	8.87	9.61	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	53000000	[M+H]+	34	2	pos	716.5222	7.83	7.54	8.16	PE	PE";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	21000000	[M+NH4]+	36	2	pos	792.5747	7.67	7.38	8.06	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	17000000	[M+H]+	32	2	pos	688.4912	6.59	6.27	6.89	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	16000000	[M+H]+	36	2	pos	786.6003	8.91	8.66	9.4	PC	PC";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (32:1) => (16:1/16:0)	PE(32:1)	in vitro	15000000	[M+H]+	32	1	pos	690.5063	7.7	7.42	8.01	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (34:1) => (16:0/18:1)	PE(34:1)	in vitro	14000000	[M+H]+	34	1	pos	718.5377	8.98	8.48	9.33	PE	PE";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	10000000	[M+NH4]+	34	2	pos	764.5432	6.52	6.14	6.81	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (35:2) => (18:1/17:1)	PE(35:2)	in vitro	5300000	[M+H]+	35	2	pos	730.5392	8.58	7.58	9.03	PE	PE";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (34:1) =>(16:0/18:1)	PG(34:1)	in vitro	4600000	[M+NH4]+	34	1	pos	766.5594	7.54	7.21	7.8	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	2600000	[M+NH4]+	32	1	pos	738.5272	6.48	6.03	10.88	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	2500000	[M+H]+	36	2	pos	775.5476	7.68	7.34	8.01	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (33:2) => (16:1/17:1)	PE(33:2)	in vitro	2100000	[M+H]+	33	2	pos	702.5072	7.38	7.07	7.67	PE	PE";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	1600000	[M+NH4]+	32	2	pos	736.5128	5.5	5.04	5.74	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (37:2) => (18:1/19:1)	PE(37:2)	in vitro	1600000	[M+H]+	37	2	pos	758.5691	10.04	9.83	10.34	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (33:1) => (16:0/17:1)	PE(33:1)	in vitro	1500000	[M+H]+	33	1	pos	704.5223	8.53	8.27	8.95	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	1300000	[M+H]+	34	2	pos	747.5165	6.52	6.14	6.76	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (30:1) => (14:0/16:1)	PE(30:1)	in vitro	1200000	[M+H]+	30	1	pos	662.4756	6.45	6.05	7.11	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	640000	[M+H]+	34	1	pos	749.5327	7.54	7.21	7.77	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	570000	[M+NH4]+	35	2	pos	778.5595	7.24	6.52	7.74	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (35:1) => (16:0/19:1)	PE(35:1)	in vitro	500000	[M+H]+	35	1	pos	732.5532	9.9	9.63	11.04	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (36:3) => (18:2/18:1)	PE(36:3)	in vitro	480000	[M+H]+	36	3	pos	742.5378	8.66	8.4	9.13	PE	PE";;;;
"STARD10	START	[M+Na]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	460000	[M+Na]+	36	2	pos	808.5819	8.92	8.66	9.27	PC	PC";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (37:2) => (18:1/19:1)	PG(37:2)	in vitro	390000	[M+NH4]+	37	2	pos	806.5905	8.49	8.18	8.78	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	380000	[M+H]+	32	1	pos	721.5007	6.39	6.01	6.64	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (36:3) => (18:2/18:1)	PG(36:3)	in vitro	380000	[M+NH4]+	36	3	pos	790.5592	7.3	6.94	7.55	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (30:2) => (16:1/14:1)	PE(30:2)	in vitro	340000	[M+H]+	30	2	pos	660.4601	5.53	5.17	5.78	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (34:3) => (18:2/16:1)	PE(34:3)	in vitro	290000	[M+H]+	34	3	pos	714.5067	7.41	6.83	7.7	PE	PE";;;;
"STARD10	START	[M+Na]+: Phosphatidylglycerol (34:1)";"Bismonoacylglycerolphosphate (34:1)	PG/BMP(34:1)	in vitro	280000	[M+Na]+	34	1	pos	771.5143	7.53	7.16	7.76	PG";" BMP	PG/BMP";;
"STARD10	START	[M+Na]+: Phosphatidylethanolamine (35:2)	PE(35:2)	in vitro	240000	[M+Na]+	35	2	pos	752.52	8.67	8.4	8.94	PE	PE";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (30:1) => (14:0/16:1)	PG(30:1)	in vitro	220000	[M+NH4]+	30	1	pos	710.4963	5.38	4.9	5.85	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	200000	[M+H]+	32	2	pos	719.486	5.5	5.08	5.72	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (38:2) => (20:1/18:1)	PE(38:2)	in vitro	190000	[M+H]+	38	2	pos	772.587	10.34	8.01	10.98	PE	PE";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (34:3) => (18:2/16:1)	PG(34:3)	in vitro	190000	[M+NH4]+	34	3	pos	762.5283	6.21	5.78	6.45	PG	PG";;;;
"STARD10	START	[M+Na]+: Phosphatidylglycerol (32:1)";"Bismonoacylglycerolphosphate (32:1)	PG/BMP(32:1)	in vitro	170000	[M+Na]+	32	1	pos	743.4827	6.41	6.01	6.64	PG";" BMP	PG/BMP";;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	170000	[M+NH4]+	33	2	pos	750.5282	6.14	5.74	6.66	PG	PG";;;;
"STARD10	START	[M+Na]+: Bismonoacylglycerolphosphate (32:2)";"Phosphatidylglycerol (32:2)	PG/BMP(32:2)	in vitro	130000	[M+Na]+	32	2	pos	741.4674	5.5	5.04	5.76	PG";" BMP	PG/BMP";;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	130000	[M+NH4]+	33	1	pos	752.5424	7.12	6.72	7.62	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (34:2) => (18:2/16:0)	PG(34:2)	in vitro	120000	[M+NH4]+	34	2	pos	764.5439	7.16	6.99	7.47	PG	PG";;;;
"STARD10	START	[M+Na]+: Phosphatidylethanolamine (37:2)	PE(37:2)	in vitro	100000	[M+Na]+	37	2	pos	780.5535	10.16	9.83	10.68	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylcholine (36:3)	PC(36:3)	in vitro	89000	[M+H]+	36	3	pos	784.5861	7.85	7.54	8.45	PC	PC";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (35:1) => (16:0/19:1)	PG(35:1)	in vitro	79000	[M+NH4]+	35	1	pos	780.5747	8.35	8.05	8.62	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (36:1) => (18:1/18:0)	PG(36:1)	in vitro	69000	[M+NH4]+	36	1	pos	794.5899	8.86	8.6	9.05	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (38:2) => (20:1/18:1)	PG(38:2)	in vitro	66000	[M+NH4]+	38	2	pos	820.6049	8.9	8.62	9.13	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	59000	[M+H]+	35	2	pos	761.531	7.17	6.89	7.35	PG	PG";;;;
"STARD10	START	[M+Na]+: Phosphatidylethanolamine (33:2)	PE(33:2)	in vitro	58000	[M+Na]+	33	2	pos	724.4862	7.36	7.22	7.55	PE	PE";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (37:2) => (18:1/19:1)	PG(37:2)	in vitro	50000	[M+H]+	37	2	pos	789.5638	8.49	8.22	8.75	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylethanolamine (31:1) => (14:0/17:1)	PE(31:1)	in vitro	50000	[M+H]+	31	1	pos	676.4917	7.12	6.85	7.42	PE	PE";;;;
"STARD10	START	[M+Na]+: Phosphatidylglycerol (35:2)	PG(35:2)	in vitro	43000	[M+Na]+	35	2	pos	783.5146	7.21	6.89	7.47	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (37:2) => (18:1/19:1)	PG(37:2)	in vitro	33000	[M+NH4]+	37	2	pos	806.5892	7.61	7.5	7.73	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (30:2) => (16:1/14:1)	PG(30:2)	in vitro	31000	[M+NH4]+	30	2	pos	708.4809	4.7	4.22	5.13	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (32:2) => (16:2/16:0)	PG(32:2)	in vitro	22000	[M+NH4]+	32	2	pos	736.5131	6.07	5.89	6.32	PG	PG";;;;
"STARD10	START	[M+NH4]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	18000	[M+NH4]+	35	2	pos	778.5564	6.48	6.12	6.66	PG	PG";;;;
"STARD10	START	[M+H]+: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	13000	[M+H]+	33	2	pos	733.4995	6.12	5.83	6.25	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	27000000	[M-H]-	34	2	neg	714.5089	7.81	7.56	8.12	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	23000000	[M-H]-	36	2	neg	742.5403	9.13	8.86	9.58	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	16000000	[M-H]-	36	2	neg	773.5346	7.65	7.36	8.04	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	11000000	[M-H]-	32	2	neg	686.4774	6.57	6.32	6.86	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	11000000	[M-H]-	34	2	neg	745.5037	6.5	6.19	6.77	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (32:1) => (16:1/16:0)	PE(32:1)	in vitro	7700000	[M-H]-	32	1	neg	688.4929	7.68	7.44	7.98	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in vitro	5800000	[M-H]-	34	1	neg	716.5247	8.97	8.76	9.28	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	4600000	[M-H]-	34	1	neg	747.5192	7.5	7.23	7.8	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (35:2) => (17:1/18:1)	PE(35:2)	in vitro	3000000	[M-H]-	35	2	neg	728.5252	8.64	8.43	8.97	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	3000000	[M-H]-	32	1	neg	719.4879	6.39	6.09	6.65	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	1800000	[M-H]-	32	2	neg	717.4709	5.42	4.72	5.75	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (33:2) => (16:1/17:1)	PE(33:2)	in vitro	1400000	[M-H]-	33	2	neg	700.4938	7.36	7.13	7.66	PE	PE";;;;
"STARD10	START	[M+HCOO]-: Phosphatidylcholine (36:2) => (18:1/18:1)	PC(36:2)	in vitro	1300000	[M+HCOO]-	36	2	neg	830.5931	8.88	8.69	9.27	PC	PC";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (37:2) => (19:1/18:1)	PE(37:2)	in vitro	870000	[M-H]-	37	2	neg	756.5562	10.02	9.82	10.3	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (30:1) => (16:1/14:0)	PE(30:1)	in vitro	850000	[M-H]-	30	1	neg	660.4618	6.36	6.12	6.74	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (33:1) => (17:1/16:0)	PE(33:1)	in vitro	840000	[M-H]-	33	1	neg	702.5091	8.51	8.3	8.8	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	610000	[M-H]-	35	2	neg	759.5193	7.21	6.95	7.44	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (37:2) => (19:1/18:1)	PG(37:2)	in vitro	440000	[M-H]-	37	2	neg	787.5511	8.45	8.21	8.71	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (36:3) => (18:2/18:1)	PG(36:3)	in vitro	410000	[M-H]-	36	3	neg	771.5194	7.27	7.01	7.52	PG	PG";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	280000	[M-H+1x(HCOONa)]-	36	2	neg	810.5268	9.13	8.9	9.47	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (30:1) => (16:1/14:0)	PG(30:1)	in vitro	270000	[M-H]-	30	1	neg	691.4566	5.32	5.01	5.61	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (36:3) => (18:1/18:2)	PE(36:3)	in vitro	250000	[M-H]-	36	3	neg	740.5245	8.64	8.43	8.91	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (35:1) => (19:1/16:0)	PE(35:1)	in vitro	240000	[M-H]-	35	1	neg	730.5407	9.88	9.69	10.19	PE	PE";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	240000	[M-H+1x(HCOONa)]-	34	2	neg	782.4949	7.82	7.6	8.17	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (30:2) => (14:1/16:1)	PE(30:2)	in vitro	230000	[M-H]-	30	2	neg	658.4463	5.53	5.28	5.77	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (34:3) => (18:2/16:1)	PG(34:3)	in vitro	220000	[M-H]-	34	3	neg	743.4884	6.18	5.89	6.41	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (34:3) => (16:1/18:2)	PE(34:3)	in vitro	180000	[M-H]-	34	3	neg	712.4931	7.39	6.82	7.67	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	170000	[M-H]-	33	2	neg	731.4881	6.11	5.84	6.31	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (34:2) => (18:2/16:0)	PG(34:2)	in vitro	160000	[M-H]-	34	2	neg	745.5044	7.14	6.94	7.4	PG	PG";;;;
"STARD10	START	[M-H]-:Phosphatidylglycerol (33:1) => (17:1/16:0)	PG(33:1)	in vitro	160000	[M-H]-	33	1	neg	733.5032	7.09	6.4	7.3	PG	PG";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	130000	[M-H+1x(HCOONa)]-	36	2	neg	841.5209	7.6	7.32	7.84	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (35:1) => (19:1/16:0)	PG(35:1)	in vitro	100000	[M-H]-	35	1	neg	761.5353	8.32	8.06	8.59	PG	PG";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	92000	[M-H+1x(HCOONa)]-	32	2	neg	754.4641	6.57	6.32	6.83	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (38:2) => (20:1/18:1)	PE(38:2)	in vitro	86000	[M-H]-	38	2	neg	770.5727	10.46	10.28	10.72	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	85000	[M-H]-	34	2	neg	813.4898	6.47	6.19	6.72	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (36:1) => (18:1/18:0)	PG(36:1)	in vitro	82000	[M-H]-	36	1	neg	775.5507	8.81	8.58	9.07	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (36:1) => (18:1/18:0)	PE(36:1)	in vitro	74000	[M-H]-	36	1	neg	744.5566	10.41	10.2	10.73	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (38:2) => (20:1/18:1)	PG(38:2)	in vitro	65000	[M-H]-	38	2	neg	801.566	8.86	8.65	9.07	PG	PG";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in vitro	64000	[M-H+1x(HCOONa)]-	34	1	neg	784.511	8.96	8.76	9.27	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (28:1) => (16:1/12:0)	PE(28:1)	in vitro	54000	[M-H]-	28	1	neg	632.4309	5.24	5.01	5.61	PE	PE";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (32:1) => (16:1/16:0)	PE(32:1)	in vitro	46000	[M-H+1x(HCOONa)]-	32	1	neg	756.4795	7.68	7.44	7.96	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (30:2) => (16:1/14:1)	PG(30:2)	in vitro	43000	[M-H]-	30	2	neg	689.4388	4.57	3.79	5.09	PG	PG";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	38000	[M-H+1x(HCOONa)]-	34	1	neg	815.5061	7.5	7.23	7.7	PG	PG";;;;
"STARD10	START	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (35:2) => (17:1/18:1)	PE(35:2)	in vitro	38000	[M-H+1x(HCOONa)]-	35	2	neg	796.5117	8.64	8.43	8.87	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylethanolamine (31:1) => (17:1/14:0)	PE(31:1)	in vitro	36000	[M-H]-	31	1	neg	674.4778	7.13	6.89	7.36	PE	PE";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (32:2) => (16:2/16:0)	PG(32:2)	in vitro	33000	[M-H]-	32	2	neg	717.4722	6.04	5.9	6.24	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (32:3)";"Bismonoacylglycerolphosphate (32:3) => (16:2/16:1)	PG/BMP(32:3)	in vitro	29000	[M-H]-	32	3	neg	715.4567	5.22	4.9	5.41	PG";" BMP	PG/BMP";;
"STARD10	START	[M-H+1x(HCOOHNa)]-: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	23000	[M-H+1x(HCOONa)]-	32	1	neg	787.475	6.38	6.09	6.6	PG	PG";;;;
"STARD10	START	[M-H]-: Phosphatidylglycerol (28:1)";"Bismonoacylglycerolphosphate (28:1) => (16:1/12:0)	PG/BMP(28:1)	in vitro	16000	[M-H]-	28	1	neg	663.4258	4.47	4.16	4.75	PG";" BMP	PG/BMP";;
"TTPA	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	1100000	[M+NH4]+	32	2	pos	736.5123	5.73	4.25	6.05	PG	PG";;;;
"TTPA	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (30:1)  => (14:0/16:1)	PG(30:1)	in vitro	300000	[M+NH4]+	30	1	pos	710.4949	5.6	4.13	5.99	PG	PG";;;;
"TTPA	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	140000	[M+Na]+	32	2	pos	741.4673	5.72	4.34	6.01	PG	PG";;;;
"TTPA	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	78000	[M+H]+	32	2	pos	719.4855	5.72	4.38	5.97	PG	PG";;;;
"TTPA	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	27000	[M+H]+	35	2	pos	761.5325	7.6	7.29	7.8	PG	PG";;;;
"TTPA	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (34:2)";"Bismonoacylglycerolphosphate (34:2) => (16:1/18:1)	PG/BMP(34:2)	in vitro	2100000	[M-H]-	34	2	neg	745.5032	6.82	5.64	7.1	PG";" BMP	PG/BMP";;
"TTPA	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (32:1)";"Bismonoacylglycerolphosphate (32:1) => (16:1/16:0)	PG/BMP(32:1)	in vitro	900000	[M-H]-	32	1	neg	719.4874	6.71	5.41	6.96	PG";" BMP	PG/BMP";;
"TTPA	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (35:2) => (17:1/18:1)	PG(35:2)	in vitro	350000	[M-H]-	35	2	neg	759.518	7.58	6.6	7.85	PG	PG";;;;
"TTPA	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (33:1)";"Phosphatidylglycerol (33:1) => (17:1/16:0)	PG/BMP(33:1)	in vitro	340000	[M-H]-	33	1	neg	733.5029	7.45	6.37	7.71	BMP";" PG	PG/BMP";;
"TTPA	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	290000	[M-H]-	32	2	neg	717.4716	5.72	4.56	5.95	PG	PG";;;;
"TTPA	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (32:2)";"Phosphatidylglycerol (32:2) => (16:1/16:1)	PG/BMP(32:2)	in vitro	170000	[M-H]-	32	2	neg	717.4717	6.5	4.43	7.46	PG";" BMP	PG/BMP";;
"TTPA	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (30:1) => (16:1/14:0)	PG(30:1)	in vitro	110000	[M-H]-	30	1	neg	691.4559	5.54	4.32	5.8	PG	PG";;;;
"TTPA	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (33:2)";"Phosphatidylglycerol (33:2) => (16:1/17:1)	PG/BMP(33:2)	in vitro	92000	[M-H]-	33	2	neg	731.4868	6.4	5.27	6.64	PG";" BMP	PG/BMP";;
"TTPA	CRAL-TRIO	[M-H]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	47000	[M-H]-	34	2	neg	671.4664	7.29	6.69	7.75	PA	PA";;;;
"TTPA	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (34:2)";"Bismonoacylglycerolphosphate (34:2) => (16:1/18:1)	PG/BMP(34:2)	in vitro	31000	[M-H+1x(HCOONa)]-	34	2	neg	813.4897	6.81	5.79	7.05	PG";" BMP	PG/BMP";;
"TTPA	CRAL-TRIO	[M-H]-: Phosphatidate (32:1) => (16:0/16:1)	PA(32:1)	in vitro	16000	[M-H]-	32	1	neg	645.4507	7.16	6.79	7.56	PA	PA";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	17000000	[M+NH4]+	36	2	pos	792.5743	8.01	7.19	8.53	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (33:1) => (16:0/17:1)	PE(33:1)	in vitro	11000000	[M+H]+	33	1	pos	704.522	8.62	8.23	8.99	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	10000000	[M+NH4]+	33	1	pos	752.543	7.45	6.4	7.77	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	9000000	[M+NH4]+	35	2	pos	778.5585	7.57	6.63	7.92	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	8700000	[M+NH4]+	34	1	pos	766.5586	7.89	6.77	8.21	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (35:2) => (18:1/17:1)	PE(35:2)	in vitro	7300000	[M+H]+	35	2	pos	730.5374	8.76	8.37	9.14	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (34:1) => (16:0/18:1)	PE(34:1)	in vitro	6500000	[M+H]+	34	1	pos	718.5378	9.1	8.71	9.5	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	6300000	[M+H]+	34	2	pos	716.5215	7.92	7.45	8.64	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	6000000	[M+NH4]+	34	2	pos	764.5432	6.81	5.71	7.32	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (32:1) => (16:1/16:0)	PE(32:1)	in vitro	4900000	[M+H]+	32	1	pos	690.5063	7.79	7.25	8.14	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	4000000	[M+NH4]+	32	1	pos	738.5278	6.7	5.49	7.01	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (35:1) => (16:0/19:1)	PG(35:1)	in vitro	3800000	[M+NH4]+	35	1	pos	780.5742	8.74	8.07	9.04	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (37:2) => (18:1/19:1)	PG(37:2)	in vitro	3100000	[M+NH4]+	37	2	pos	806.5902	8.87	8.19	9.15	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (35:1) => (16:0/19:1)	PE(35:1)	in vitro	1700000	[M+H]+	35	1	pos	732.5534	10.01	9.66	10.4	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (33:2) => (16:1/17:1)	PE(33:2)	in vitro	1400000	[M+H]+	33	2	pos	702.5063	7.44	6.95	7.77	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	1300000	[M+H]+	33	1	pos	735.516	7.45	6.55	7.71	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	1300000	[M+H]+	36	2	pos	775.5476	8.01	7.17	8.54	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (37:2) => (18:1/19:1)	PE(37:2)	in vitro	1200000	[M+H]+	37	2	pos	758.5693	10.03	9.01	10.47	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	1100000	[M+Na]+	36	2	pos	797.5291	8.01	7.11	8.53	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	1000000	[M+H]+	34	1	pos	749.5321	7.88	7.03	8.15	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (30:0) => (14:0/16:0)	PE(30:0)	in vitro	890000	[M+H]+	30	0	pos	664.4904	7.53	7.01	7.84	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	880000	[M+NH4]+	33	2	pos	750.5278	6.41	5.3	7.4	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	790000	[M+H]+	35	2	pos	761.5308	7.56	6.69	7.81	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (33:1) => (16:0/17:1)	PG(33:1)	in vitro	710000	[M+Na]+	33	1	pos	757.498	7.45	6.44	7.74	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (34:1)	PG(34:1)	in vitro	670000	[M+Na]+	34	1	pos	771.5134	7.89	6.72	8.21	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (30:1) => (14:0/16:1)	PE(30:1)	in vitro	670000	[M+H]+	30	1	pos	662.4757	6.43	5.88	6.82	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	640000	[M+H]+	32	2	pos	688.4912	6.64	6.11	7.36	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (34:2) => (18:1/16:1)	PG(34:2)	in vitro	550000	[M+Na]+	34	2	pos	769.4983	6.83	5.76	7.31	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (35:2) => (18:1/17:1)	PG(35:2)	in vitro	540000	[M+Na]+	35	2	pos	783.5133	7.58	6.61	7.86	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	530000	[M+Na]+	36	2	pos	766.5347	9.24	8.84	9.8	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (31:1) => (14:0/17:1)	PE(31:1)	in vitro	520000	[M+H]+	31	1	pos	676.4908	7.21	6.72	7.53	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (35:1) => (16:0/19:1)	PG(35:1)	in vitro	500000	[M+H]+	35	1	pos	763.5474	8.73	8.02	9.02	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (30:1) => (16:0/14:1)	PG(30:1)	in vitro	470000	[M+NH4]+	30	1	pos	710.4951	5.61	4.21	6.1	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	460000	[M+H]+	34	2	pos	747.5161	6.81	5.84	7.3	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylcholine (36:2)	PC(36:2)	in vitro	420000	[M+H]+	36	2	pos	786.6003	8.98	8.33	9.73	PC	PC";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	420000	[M+NH4]+	32	2	pos	736.5123	5.74	4.04	7.47	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (30:0) => (14:0/16:0)	PG(30:0)	in vitro	410000	[M+NH4]+	30	0	pos	712.5119	6.48	5.3	6.73	PG	PG";;;;
"TTPAL	CRAL-TRIO	 [M+Na]+: Phosphatidylglycerol (32:1)  => (16:1/16:0)	PG(32:1)	in vitro	380000	[M+Na]+	32	1	pos	743.4831	6.7	5.57	7	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in vitro	370000	[M+Na]+	34	1	pos	740.519	9.09	8.71	9.46	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (35:1) => (16:0/19:1)	PG(35:1)	in vitro	360000	[M+Na]+	35	1	pos	785.529	8.74	8.02	9.05	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (31:1) => (14:0/17:1)	PG(31:1)	in vitro	350000	[M+NH4]+	31	1	pos	724.5098	6.19	5.08	7.49	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	340000	[M+H]+	32	1	pos	721.5004	6.7	5.61	6.93	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylethanolamine (35:2) => (18:1/17:1)	PE(35:2)	in vitro	330000	[M+Na]+	35	2	pos	752.5189	8.76	8.37	9.09	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (37:2) => (18:1/19:1)	PG(37:2)	in vitro	310000	[M+H]+	37	2	pos	789.5639	8.84	8.17	9.66	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (37:2) => (18:1/19:1)	PG(37:2)	in vitro	290000	[M+Na]+	37	2	pos	811.5451	8.87	8.13	9.15	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (32:0) => (16:0/16:0)	PE(32:0)	in vitro	240000	[M+H]+	32	0	pos	692.522	8.95	8.42	9.36	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (36:1) => (18:1/18:0)	PG(36:1)	in vitro	220000	[M+NH4]+	36	1	pos	794.5895	9.23	8.86	9.5	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (36:3) => (18:2/18:1)	PG(36:3)	in vitro	190000	[M+NH4]+	36	3	pos	790.5582	7.59	6.9	8.5	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylethanolamine (35:1)	PE(35:1)	in vitro	170000	[M+Na]+	35	1	pos	754.5356	10.01	9.66	10.35	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (36:1) => (18:1/18:0)	PE(36:1)	in vitro	100000	[M+H]+	36	1	pos	746.569	10.54	10.18	11.27	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (32:0) => (16:0/16:0)	PG(32:0)	in vitro	90000	[M+NH4]+	32	0	pos	740.5427	7.73	5.63	7.93	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylethanolamine (34:1) => (16:0/16:1)	PE(32:1)	in vitro	89000	[M+NH4]+	32	1	pos	735.5635	7.77	7.49	8.07	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (28:0) => (14:0/14:0)	PG(28:0)	in vitro	84000	[M+NH4]+	28	0	pos	684.4815	5.36	4.2	6.51	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (28:0) => (14:0/14:0)	PE(28:0)	in vitro	83000	[M+H]+	28	0	pos	636.4595	6.19	5.62	6.49	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	83000	[M+Na]+	33	2	pos	755.4828	6.39	5.32	6.61	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (30:1) => (14:0/16:1)	PG(30:1)	in vitro	60000	[M+Na]+	30	1	pos	715.4519	5.54	4.28	5.81	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (28:1) => (12:0/16:1)	PG(28:1)	in vitro	51000	[M+NH4]+	28	1	pos	682.4647	4.61	3.56	4.95	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (38:2) => (19:1/19:1)	PE(38:2)	in vitro	42000	[M+H]+	38	2	pos	772.5869	10.99	10.53	11.37	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	41000	[M+Na]+	32	2	pos	741.4673	5.73	4.53	6.33	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylcholine (O-18:1)";"Lysophosphatidylcholine (18:1)	PC(O-18:1)/LPC(18:1)	in vitro	41000	[M+H]+	18	1	pos	522.3557	2.26	1.24	2.45	PC-O";" Lyso-PC	LPC";;
"TTPAL	CRAL-TRIO	[M+H]+: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	38000	[M+H]+	17	1	pos	466.2927	1.99	0.86	2.12	Lyso-PE	LPE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Cardiolipin (69:3)	CL(69:3)	in vitro	37000	[M+NH4]+	69	3	pos	1435.0348	16.66	16.34	16.85	CL	CL";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (37:1) => (19:1/18:0)	PG(37:1)	in vitro	35000	[M+NH4]+	37	1	pos	808.6058	10.09	9.55	10.34	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Cardiolipin (70:3) => (18:1/18:1/18:1/16:0)	CL(70:3)	in vitro	35000	[M+NH4]+	70	3	pos	1449.0518	16.75	16.39	16.98	CL	CL";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylglycerol (30:1) => (14:0/16:1)	PG(30:1)	in vitro	34000	[M+H]+	30	1	pos	693.4699	5.54	4.49	5.81	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Cardiolipin (68:3)	CL(68:3)	in vitro	33000	[M+NH4]+	68	3	pos	1421.0176	16.51	16.16	16.77	CL	CL";;;;
"TTPAL	CRAL-TRIO	[M+Na]+: Phosphatidylglycerol (31:1)	PG(31:1)	in vitro	30000	[M+Na]+	31	1	pos	729.4676	6.2	5.1	6.37	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Phosphatidylethanolamine (30:2) => (16:1/14:1)	PE(30:2)	in vitro	29000	[M+H]+	30	2	pos	660.4601	5.55	4.95	6.86	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M+H]+:Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	28000	[M+H]+	33	2	pos	733.4986	6.4	6.32	6.53	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (29:1) => (12:0/17:1)	PG(29:1)	in vitro	21000	[M+NH4]+	29	1	pos	696.4795	5.38	4.11	6.49	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+H]+: Lysophosphatidylethanolamine (16:0) => (16:0)	LPE(16:0)	in vitro	19000	[M+H]+	16	0	pos	454.2923	2.18	1.11	2.33	Lyso-PE	LPE";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Phosphatidylglycerol (30:2) => (14:1/16:1)	PG(30:2)	in vitro	19000	[M+NH4]+	30	2	pos	708.481	4.83	4.07	5.59	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M+NH4]+: Cardiolipin (67:2) => (16:0/18:1//16:0/17:1)	CL(67:2)	in vitro	15000	[M+NH4]+	67	2	pos	1409.0205	16.66	16.36	16.85	CL	CL";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	8400000	[M-H]-	36	2	neg	773.5337	8.01	7.19	8.53	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (33:1) => (17:1/16:0)	PG(33:1)	in vitro	6200000	[M-H]-	33	1	neg	733.5025	7.45	6.54	7.73	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	5300000	[M-H]-	34	1	neg	747.5183	7.89	7.15	8.19	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (35:2) => (17:1/18:1)	PG(35:2)	in vitro	4700000	[M-H]-	35	2	neg	759.5178	7.57	6.69	7.84	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	4300000	[M-H]-	34	2	neg	745.5027	6.82	5.79	7.3	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (33:1) => (17:1/16:0)	PE(33:1)	in vitro	4000000	[M-H]-	33	1	neg	702.5078	8.62	8.22	8.94	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	2700000	[M-H]-	32	1	neg	719.4871	6.71	5.6	6.95	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	2400000	[M-H]-	36	2	neg	742.5396	9.23	8.87	9.79	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (35:1) => (19:1/16:0)	PG(35:1)	in vitro	2300000	[M-H]-	35	1	neg	761.5335	8.74	8.03	9.04	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (35:2) => (17:1/18:1)	PE(35:2)	in vitro	2300000	[M-H]-	35	2	neg	728.5237	8.75	8.36	9.07	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in vitro	2300000	[M-H]-	34	1	neg	716.5238	9.1	8.72	9.47	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (37:2) => (19:1/18:1)	PG(37:2)	in vitro	1900000	[M-H]-	37	2	neg	787.5492	8.87	8.18	9.17	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (34:2) => (16:1/18:1)	PE(34:2)	in vitro	1800000	[M-H]-	34	2	neg	714.5079	7.92	7.46	8.48	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (32:1) => (16:1/16:0)	PE(32:1)	in vitro	1600000	[M-H]-	32	1	neg	688.4918	7.78	7.29	8.12	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (33:2) => (16:1/17:1)	PG(33:2)	in vitro	600000	[M-H]-	33	2	neg	731.4869	6.41	5.53	6.66	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (33:2) => (17:1/16:1)	PE(33:2)	in vitro	470000	[M-H]-	33	2	neg	700.4919	7.44	6.97	7.75	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (30:0) => (14:0/16:0)	PE(30:0)	in vitro	310000	[M-H]-	30	0	neg	662.4763	7.53	7.06	7.79	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (30:0) => (14:0/16:0)	PG(30:0)	in vitro	310000	[M-H]-	30	0	neg	693.4712	6.48	5.47	6.72	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (30:1) => (16:1/14:0)	PE(30:1)	in vitro	280000	[M-H]-	30	1	neg	660.4611	6.43	5.91	6.8	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (30:1) => (14:1/16:0)	PG(30:1)	in vitro	260000	[M-H]-	30	1	neg	691.4557	5.55	4.54	5.84	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (32:2) => (16:1/16:1)	PE(32:2)	in vitro	240000	[M-H]-	32	2	neg	686.4766	6.65	6.12	6.97	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (32:2) => (16:1/16:1)	PG(32:2)	in vitro	230000	[M-H]-	32	2	neg	717.4716	5.73	4.77	6.39	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (31:1) => (17:1/14:0)	PE(31:1)	in vitro	200000	[M-H]-	31	1	neg	674.4764	7.21	6.73	7.48	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (31:1) => (17:1/14:0)	PG(31:1)	in vitro	200000	[M-H]-	31	1	neg	705.4711	6.2	5.33	6.42	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (36:2) => (18:1/18:1)	PG(36:2)	in vitro	120000	[M-H+1x(HCOONa)]-	36	2	neg	841.5205	8.01	7.27	8.51	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (36:3) => (18:1/18:2)	PG(36:3)	in vitro	88000	[M-H]-	36	3	neg	771.5163	7.59	6.85	8.06	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (33:1) => (17:1/16:0)	PG(33:1)	in vitro	88000	[M-H+1x(HCOONa)]-	33	1	neg	801.4887	7.43	6.64	7.71	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (33:1) => (17:1/16:0)	PE(33:1)	in vitro	77000	[M-H+1x(HCOONa)]-	33	1	neg	770.4949	8.62	8.22	8.95	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (34:1) => (18:1/16:0)	PG(34:1)	in vitro	77000	[M-H+1x(HCOONa)]-	34	1	neg	815.5043	7.86	7.08	8.21	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (38:2)";"Phosphatidylglycerol (38:2) => (19:1/19:1)	PG/BMP(38:2)	in vitro	75000	[M-H]-	38	2	neg	801.565	9.43	8.78	9.99	PG";" BMP	PG/BMP";;
"TTPAL	CRAL-TRIO	[M-H]-: octadecenoate => (18:1)	FA(18:1)	in vitro	72000	[M-H]-	18	1	neg	281.2482	3.82	3.24	4.05	FA	FA";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (35:2) => (17:1/18:1)	PG(35:2)	in vitro	59000	[M-H+1x(HCOONa)]-	35	2	neg	827.5046	7.56	6.85	7.8	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	59000	[M-H+1x(HCOONa)]-	36	2	neg	810.5261	9.23	8.87	9.76	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (34:2) => (16:1/18:1)	PG(34:2)	in vitro	55000	[M-H+1x(HCOONa)]-	34	2	neg	813.4895	6.81	6.07	7.27	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (28:0) => (14:0/14:0)	PG(28:0)	in vitro	54000	[M-H]-	28	0	neg	665.4405	5.37	4.36	5.58	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in vitro	54000	[M-H+1x(HCOONa)]-	34	1	neg	784.5106	9.1	8.73	9.42	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Lysophosphatidylethanolamine (18:1) => (18:1)	LPE(18:1)	in vitro	53000	[M-H]-	18	1	neg	478.2942	2.34	1.24	2.48	Lyso-PE	LPE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (30:1)";"Phosphatidylglycerol (30:1) => (14:1/16:0)	PG/BMP(30:1)	in vitro	47000	[M-H]-	30	1	neg	691.4558	6.18	4.85	7.32	PG";" BMP	PG/BMP";;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidate (34:2) => (18:1/16:1)	PA(34:2)	in vitro	45000	[M-H]-	34	2	neg	671.4656	7.24	6.57	7.78	PA	PA";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidate (32:1) => (16:0/16:1)	PA(32:1)	in vitro	45000	[M-H]-	32	1	neg	645.4492	7.16	6.46	7.52	PA	PA";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (32:0) => (16:0/16:0)	PG(32:0)	in vitro	44000	[M-H]-	32	0	neg	721.502	7.72	7.36	7.98	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (32:1) => (16:1/16:0)	PG(32:1)	in vitro	44000	[M-H+1x(HCOONa)]-	32	1	neg	787.4734	6.7	5.78	6.96	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylethanolamine (35:2) => (17:1/18:1)	PE(35:2)	in vitro	43000	[M-H+1x(HCOONa)]-	35	2	neg	796.5095	8.76	8.38	9.05	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (35:1) => (19:1/16:0)	PG(35:1)	in vitro	41000	[M-H+1x(HCOONa)]-	35	1	neg	829.5203	8.73	8.1	9.03	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidate (36:2) => (18:1/18:1)	PA(36:2)	in vitro	39000	[M-H]-	36	2	neg	699.4966	8.58	7.94	9.09	PA	PA";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (28:1) => (16:1/12:0)	PG(28:1)	in vitro	36000	[M-H]-	28	1	neg	663.4239	4.62	3.57	4.97	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidate (35:2) => (18:1/17:1)	PA(35:2)	in vitro	35000	[M-H]-	35	2	neg	685.4807	8.08	7.57	8.54	PA	PA";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidate (33:1) => (16:0/17:1)	PA(33:1)	in vitro	35000	[M-H]-	33	1	neg	659.4649	7.94	7.27	8.4	PA	PA";;;;
"TTPAL	CRAL-TRIO	[M-H+1x(HCOONa)]-: Phosphatidylglycerol (37:2) => (19:1/18:1)	PG(37:2)	in vitro	34000	[M-H+1x(HCOONa)]-	37	2	neg	855.5356	8.86	8.25	9.09	PG	PG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidate (34:1) => (16:0/18:1)	PA(34:1)	in vitro	33000	[M-H]-	34	1	neg	673.4811	8.41	7.9	8.86	PA	PA";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (28:0) => (14:0/14:0)	PE(28:0)	in vitro	31000	[M-H]-	28	0	neg	634.4453	6.22	5.68	6.47	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Lysophosphatidylethanolamine (17:1) => (17:1)	LPE(17:1)	in vitro	26000	[M-H]-	17	1	neg	464.2781	2.01	0.99	2.14	Lyso-PE	LPE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Bismonoacylglycerolphosphate (34:3)";"Phosphatidylglycerol (34:3) => (16:1/18:2)	PG/BMP(34:3)	in vitro	24000	[M-H]-	34	3	neg	743.486	6.45	5.52	6.96	PG";" BMP	PG/BMP";;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (36:3) => (18:1/18:2)	PE(36:3)	in vitro	22000	[M-H]-	36	3	neg	740.5229	8.74	8.3	9.28	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H+2x(HCOONa)]-: Phosphatidylethanolamine (33:1) => (17:1/16:0)	PE(33:1)	in vitro	22000	[M-H+2x(HCOONa)]-	33	1	neg	838.4818	8.61	8.22	8.98	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H+2x(HCOONa)]-: Phosphatidylethanolamine (34:1) => (18:1/16:0)	PE(34:1)	in vitro	18000	[M-H+2x(HCOONa)]-	34	1	neg	852.4974	9.08	8.75	9.47	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H+2x(HCOONa)]-: Phosphatidylethanolamine (36:2) => (18:1/18:1)	PE(36:2)	in vitro	18000	[M-H+2x(HCOONa)]-	36	2	neg	878.5132	9.22	8.87	9.76	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylethanolamine (28:1) => (16:1/12:0)	PE(28:1)	in vitro	16000	[M-H]-	28	1	neg	632.4302	5.27	4.72	5.71	PE	PE";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Lysophosphatidylglycerol (18:1) => (18:1)	LPG(18:1)	in vitro	14000	[M-H]-	18	1	neg	509.2885	2.01	0.75	2.18	Lyso-PG	LPG";;;;
"TTPAL	CRAL-TRIO	[M-H]-: Phosphatidylglycerol (29:1)";"Bismonoacylglycerolphosphate (29:1) => (17:1/12:0)	PG/BMP(29:1)	in vitro	13000	[M-H]-	29	1	neg	677.4403	5.16	4.17	5.32	PG";" BMP	PG/BMP";;
"TTPAL	CRAL-TRIO	[M-H]-: Lysophosphatidylethanolamine (16:0) => (16:0)	LPE(16:0)	in vitro	12000	[M-H]-	16	0	neg	452.2784	2.19	1.17	2.32	Lyso-PE	LPE";;;;
